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ABSTRACT 
 
 
The aim of this research project was to determine the effectiveness of 
DaimlerChrysler South Africa’s efforts in addressing the HIV/AIDS 
pandemic. 
 
The devastating impacts of the HIV/AIDS pandemic have already been felt 
at the workplace as without further successful interventions, HIV/AIDS 
mortality at DaimlerChrysler South Africa (DCSA) was expected to peak in 
2006. 
 
Investment in HIV/AIDS programmes has been proposed as good 
business practice.  The DCSA HIV/AIDS Workplace Programme was thus 
established to limit the impact and consequences of the HIV/AIDS 
pandemic on its workers, their families and surrounding communities. 
 
The empirical survey, comprising a questionnaire, examined the attitude 
and perception of employees regarding the effectiveness of the DCSA 
HIV/AIDS Workplace Programme. 
 
The findings of the empirical survey corresponded with the findings of the 
literature survey in concluding that the DCSA HIV/AIDS Workplace 
Programme has been successful in effectively addressing the HIV/AIDS 
pandemic. 
 
A few aspects of the Workplace Programme need attention and 
recommendations have been made in order to contribute to the lowering of 
HIV/AIDS prevalence rates at DaimlerChrysler South Africa.  
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CHAPTER 1 
 
PROBLEM STATEMENT AND SCOPE OF STUDY 
 
 
1.1 INTRODUCTION 
 
HIV/AIDS is not the first global pandemic, and it certainly will not be the 
last:  It is a disease that is changing human history.   
 
As De Cock, Mbori-Ngacha and Marum (2002: 68) put it:  “HIV/AIDS is the 
greatest threat to life, liberty and the pursuit of happiness and prosperity in 
African countries.  Intervention, therefore, must be quantitatively and 
qualitatively commensurate with the magnitude of the threat posed by the 
disease”. 
   
 
1.2      MAIN PROBLEM 
 
HIV/AIDS is a serious threat to social stability and economic prosperity in 
South Africa.   
 
“HIV/AIDS is a management issue as much as it is a health and education 
issue and company directors who do not take action to protect their 
businesses against the impact of the disease are not complying with their 
fiduciary responsibilities” (Griffiths, as quoted by Savides, 2000).  
 
UNAIDS estimates that by 2006, 8 – 10 million South Africans will be 
infected with HIV/AIDS.  HIV/AIDS predominantly affects productive age 
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groups impacting on the entire economy and making HIV/AIDS the key 
development challenge for business. 
 
“AIDS has a profound impact on workers and their families, enterprises 
and national economies.  It is a workplace issue and a development 
challenge.”  Juan Somavia, ILO Director-General (www.weforum.org: 
2004). 
 
AIDS is a workplace issue because it predominantly affects working 
people and because the workplace has a vital role to play in the wider 
struggle to limit the spread and effects of the epidemic.  Parker, Kistner, 
Gelb, Kelly and O’Donovan (2000: 54) state that the impact of the 
HIV/AIDS pandemic in workplaces and on markets can be broadly 
categorised as: 
 
• Direct impacts 
• Indirect impacts 
• Systemic impacts  
 
DaimlerChrysler is one of the world’s largest automotive transportation and 
services companies.  DaimlerChrysler South Africa (DCSA) has three 
main plants that manufacture, market, import and export motor vehicles 
and automotive parts.  East London is their largest facility with 79 per cent 
of the workforce. In 2003, DCSA had 4,500 employees and 3,000 
suppliers and contractors working at these three facilities. 
 
DCSA is a major and growing contributor to the economy of the Border 
region.  The automotive industry contributes significant social and 
economic benefits to the Border region and generates much economic 
activity in other areas of South Africa involved in inter alia the manufacture 
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and supply of automotive components and the sales and servicing of 
vehicles. 
 
The potential social and economic effects of HIV/AIDS in this region are 
expected to pose a risk to the automotive industry. Damage to the 
automotive industry will feedback negatively into the economy and social 
system, creating a negative reinforcing feedback loop. 
 
In 2002 DCSA realised the need to review its HIV/AIDS policy and be 
more proactive in prevention, care, support and treatment.  The purpose of 
DCSA HIV/AIDS Workplace Policy is to ensure a uniform and fair 
approach to the effective prevention of HIV/AIDS amongst employees and 
the comprehensive management of HIV positive employees living with 
AIDS (www.daimlerchrysler.co.za:  2004).  
 
DCSA is attempting to limit the impact and consequences of the HIV/AIDS 
pandemic on its workers, their families, and surrounding communities 
through its HIV/AIDS workplace and community outreach program 
(www.weforum.org/globalhealth/cases:  2004). 
 
At the company level, the HIV/AIDS program is intended to protect and 
maintain workers’ health, and thereby to support productivity and to limit 
cost impacts.  At a larger social and political level, DCSA aims to set an 
example for a strategic and human rights oriented approach to the 
disease. 
 
These facts lead to the following problem which will be addressed by this 
research: 
 
How effective is DCSA in addressing the HIV/AIDS pandemic? 
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1.3      SUB-PROBLEMS 
 
In order to develop a research strategy to deal with and solve the main 
problem, the following sub-problems have been identified: 
 
(a)  What have previous studies shown is the impact of HIV/AIDS at the                  
       workplace? 
 
(b)  What does empirical research reveal regarding the current situation at       
       DCSA to address  the impact of HIV/AIDS? 
 
(c)  What strategic insights can be drawn from a comparison of the           
       literature study and empirical research?                       
         
 
1.4     DEMARCATION OF THE RESEARCH 
 
Demarcating the research serves the purpose of making the research 
topic manageable from a research point of view.     
 
1.4.1   The industry 
 
The automotive industry will be the focus of this research. 
 
1.4.2   The organisation 
 
DaimlerChrysler South Africa.   
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1.4.3   Geographical demarcation 
 
The empirical component of this study will be limited to the East London 
plant of DCSA. 
 
1.4.4    Employment level 
 
The study will be conducted on a stratified random sample of 50 
employees.  The sample will be selected from across the various job-
bands in DCSA and will be stratified by job grade into the following 3 
strata: 
 
• Hourly paid employees (i.e. all plant and service support 
employees); 
• Management (both senior and middle management i.e. job grades 
1 – 5); and 
• Administrative (job grades 6 – 8). 
 
1.4.5   Time period 
 
The analysis will be undertaken during the second trimester of the year 
2004. 
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1.5     DEFINITION OF SELECTED CONCEPTS 
 
1.5.1 HIV/AIDS 
 
AIDS (Acquired Immune Deficiency Syndrome) is caused by a virus 
called HIV (Human Immune Deficiency Virus).  This virus slowly 
weakens a person’s ability to fight off other diseases, by attaching 
itself to and destroying important cells that control and support the 
human immune system (www.aidsconsortium.org.za: 2004). 
  
1.5.2 Sero-prevalence 
 
The percentage of HIV-positive results in a given sample       
(www.businessfightsaids.org: 2004). 
 
1.5.3 Epidemic 
 
An epidemic is a rate of disease that reaches unexpectedly high 
levels, affecting a large number of people in a relatively short time.  
Epidemic is a relative concept: a small absolute number of cases of 
a disease is considered an epidemic if the disease incidence is 
usually very low (Barnett & Whiteside, 2002: 25). 
 
1.5.4 Pandemic 
 
An unbound epidemic.  A pandemic describes epidemics of world-
wide proportions, such as influenza in 1918 or HIV/AIDS today 
(Barfield, 1997: 150).    
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1.6     ASSUMPTIONS 
 
According to the World Health Organization (WHO), individuals die without 
treatment on average nine years after becoming HIV-infected.  With 
modern anti retroviral treatment (ART) life expectancy can be extended 
significantly, but ultimately there is no fully effective medication or 
treatment available to cure the infected person. 
 
 
1.7     THE SIGNIFICANCE OF THE RESEARCH 
 
The Daily Dispatch (24/11/04) reports that the world is facing a “unique 
development challenge”, as new data shows nearly 40 million people now 
have HIV and over three million will die of Aids this year (2004), the 
highest toll in the 23-year history of the killer disease.  The World Health 
Organisation (WHO) and UNAIDS warned that without urgent action “the 
world is unlikely to gain the upper hand over Aids”. 
 
Peter Piot, UNAIDS CEO, states the following: “The latest developments 
firmly establish Aids as a unique development challenge.  The time for 
quick fixes and emergency responses is over.  We have to balance the 
emergency nature of the crisis with the need for sustainable solutions”  
(Daily Dispatch, 24/11/04). 
 
The HIV/AIDS epidemic has had a substantial impact in the Republic of 
South Africa.  According to UNAIDS, 360,000 people in South Africa died 
because of the disease in the year 2001 alone.  The adult prevalence rate 
in the age group of 15 to 49 years is estimated at 20.1 per cent 
(UNAIDS/WHO,  2002).  If the situation does not change, it is expected 
that the number of HIV positive people in South Africa will peak at 8 million 
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in 2007 and that in the year 2010 alone 800,000 people will die because of 
HIV/AIDS (Dorrington  & Johnson, 2002). 
 
The latest reports (Daily Dispatch, 24/11/04) indicate that Sub-Saharan 
Africa remains by far the worst-affected region in the world.  In South 
Africa, where 5,3 million people are infected, “there is no sign yet of a 
decline in the epidemic”, and HIV prevalence among pregnant women, 
which in 2003 was already 27,9 per cent, is continuing to rise. 
 
According to Fourie and Quattek, co-authors of the ING Barings report on 
the economic impact of AIDS in South Africa (2000), “South Africa is faced 
with a worsening AIDS epidemic, which will have a profound impact on the 
country’s economic outlook”. 
 
The HIV/AIDS pandemic has a significant impact on the world’s labour 
force.  The Daily Dispatch (13/7/04) reports that the world’s labour force is 
under pressure as an estimated 36,5 million people of working age are 
HIV positive, with the global labour force by next year losing as many as 
28 million workers since the start of the Aids pandemic 23 years ago. 
 
The International Labour Office (ILO), estimates that in the absence of 
increased access to treatment, the number of workers lost due to 
HIV/AIDS will increase to 48 million by 2010, and 74 million by 2015, 
making HIV/AIDS one of the biggest causes of mortality in the globe’s 
labour force (www.weforum.org: 2004). 
 
 
 
 
 
 
  9
 
HIV/AIDS has affected DCSA, like most other companies in South Africa.  
On a general business level, the Global Business Coalition on HIV/AIDS 
(GBC) identifies three major effects visible on the bottom line 
(www.businessfightsaids.org: 2004): 
• Increased costs; 
• Loss of productivity; and 
• A general threat to the basic structure of the economies in which 
companies operate. 
 
According to a United Nations study cited by the Global Business Coalition 
on HIV/AIDS, average profits in several Southern African countries are 
projected  to decrease due to HIV/AIDS by at least 6-8 per cent.  
Productivity is expected to decline by 5 per cent as a result of increased 
absenteeism, staff turnover, and lower worker morale 
(www.businessfightsaids.org: 2004).   
 
Given a HIV/AIDS prevalence rate of 9 per cent amongst its employees in 
2002 (www.hivaids.daimlerchrysler.co.za: 2004), and somewhat higher 
prevalence rates in the surrounding communities and especially at the 
national level, DCSA faces the prospect of being affected by these 
developments, thereby weakening DCSA’s position as a production centre 
within the global DaimlerChrysler network. 
 
The main goals of DCSA’s overall HIV/AIDS activities are to prevent new 
infections in the workforce and amongst dependants, provide the best 
possible care for those living with HIV/AIDS, ensure that DCSA 
systematically and progressively addresses HIV/AIDS as the key obstacle 
to sustainable development and maintain the company’s profitability in 
South Africa (www.daimlerchrysler.com: 2004).  
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1.7.1 Significance of this study in contributing to lowering HIV/AIDS 
prevalence rates at DCSA: 
 
• Awareness amongst East London employees of the DCSA 
HIV/AIDS Workplace programme; 
• Employees’ attitude and perception regarding the HIV/AIDS 
Workplace programme will be determined and analysed with the 
aim of improving aspects as identified by employees in the 
questionnaire; and 
• The final report from this research paper can contribute to the 
continuous improvement of the DCSA HIV/AIDS Workplace 
programme and thus contribute to the lowering of HIV/AIDS 
prevalence rates at DaimlerChrysler South Africa. 
 
 
1.8 RESEARCH DESIGN 
 
In this section the broad methodology that will be followed in the study is 
described. 
 
Research methodology 
The following procedure will be adopted to solve the main and sub-
problems: 
 
1.8.1 Literature survey 
 
• HIV/AIDS information and projects that address this pandemic 
will be identified from the literature. 
• DCSA HIV/AIDS workplace programme will be analysed. 
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1.8.2 Empirical study 
 
The object of the survey will be to identify: 
  
• How effectively the HIV/AIDS pandemic is being addressed at 
DCSA; 
• Employees’ attitude and perception regarding the impact of 
HIV/AIDS at the workplace; and 
• Employees’ attitude and perception regarding the effectiveness 
of the DCSA Workplace Project.  
 
The empirical study will consist of: 
 
(a)  Measuring instrument 
 
In order to conduct the survey it will be necessary to develop a 
questionnaire.  The indicators and variables included in the 
questionnaire will be informed by consultation with the relevant 
stakeholders and health care professionals at DCSA. 
The questionnaire will comprise a mix of qualitative and fixed-choice 
questions. 
  
(b)  Sample 
 
The study will be conducted on a random sample of 50 employees 
from across various job bands in DCSA. 
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(c)  Statistical analysis of data 
 
The statistical procedures to be used in interpreting and analysing the 
data will be determined in consultation with a statistician at the time the 
questionnaire is drawn up.   
 
 
1.9 CONCLUSION 
 
This concludes the first chapter of this research project which identified the 
scope of the study and the significance of the research. 
 
It was clear that DaimlerChrysler South Africa needed to actively intervene 
and manage the effects of the HIV/AIDS pandemic. 
 
Chapter 2 introduces selected theory and findings of other researchers in 
respects of HIV/AIDS and its impact on the workplace. 
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CHAPTER 2 
 
ADDRESSING THE IMPACT OF HIV/AIDS AT THE WORKPLACE 
 
 
2.1   INTRODUCTION 
 
During the period 1994 to 2004, there has been an exponential growth of 
HIV infections in South Africa, which has had a predominant effect on the 
workplace.  As a result of the growth in HIV prevalence, and the failure to 
control the spread of HIV, South Africa’s labour force faces a major AIDS 
pandemic.   
 
The number of deaths each year due to AIDS is expected to rise rapidly in 
South Africa from around 120 000 in 2000, to between 354 000 to 383 000 
in 2005, and up to 545 000 to 635 000 in 2010 (UNAIDS/WH0, 2003).  
Another source, Dorrington and Johnson (2002: 18) suggest that AIDS 
may result in 800 000 deaths in 2010.  Nationally the proportion of the 
adult population dying from AIDS will reach 2 to 2,6 per cent by 2010.   
 
The Daily Dispatch (13/07/04) reports that the International Labour Office 
(ILO) estimates that in the absence of increased access to treatment, the 
number of workers (globally) lost due to HIV/AIDS will increase to 48 
million by 2010.  It is clear from these statistics that the devastating 
impacts of this pandemic are already being felt at the workplace.  
 
South Africa’s response to HIV/AIDS has not been as comprehensive or 
directed as it may have been (Love Life, 2003: 3).  The lack of success of 
prevention means that South Africa has to deal with the impact flowing 
from the illness and death of large numbers of people.  One of the main 
problems around the pandemic is having people conceive of the size of 
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the problem and another is the enormous stigma that is still attached to 
HIV infection (Whiteside & Sunter, 2000: 141).  The future of South 
Africa’s labour force will, to a large extent, be determined by how quickly 
people realize that the impact of AIDS has to be dealt with.  Whiteside and 
Sunter (2000: 142) emphasize that one of the principal challenges for the 
private sector is to understand the benefits in providing care for their 
workers. 
 
 
2.2  DEFINING IMPACT 
 
Pandemic impacts are history-changing events.  They terminate some 
lives, incapacitate others and stunt the capabilities of those who have to 
divert energy and time into care.  In the end, sufficient numbers of deaths 
and illnesses make a society take a path other than that which it would 
previously have followed.  This is impact (Barnett & Whiteside, 2002:159).  
 
HIV/AIDS increases morbidity and mortality in populations at precisely 
those ages where normal levels of morbidity and mortality are low.  It is 
from these unusual events that other impacts flow.  These impacts may be 
felt as an immediate and severe shock or they may be more complex, 
gradual and long-term changes.   
 
In terms of impact, there is a great deal that is unknown.  Nowhere in the 
world has the pandemic run its course, and it will be many years before it 
does.  
 
According to Barnett and Whiteside (2002:163) perception and estimation 
of impact will depend on: 
• The perspective of those who are looking and the disciplinary, 
moral and political lenses they employ; and 
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• The degree to which those who are affected count in society.  The 
impacts on marginal population are least likely to be counted and 
power holders are more likely to be able to say that these people do 
not count. 
 
The fact that South Africa has a more developed economy may magnify 
the impact.  Whiteside and Sunter (2002: 66) argue that there will be two 
mechanisms at work.  Firstly, South Africa is more dependant on skilled 
labour than other countries in the region, and the skills base is extremely 
small.  Losses of skilled and professional staff could hamper business and 
government operations, and possibly slow economic growth.  The second 
mechanism is that South Africans have more interaction with and 
expectations of service from their government than is the case in the rest 
of Africa. 
 
This means that the expectations of assistance and health care as the 
pandemic develops will be greater.  Concurrently, the human resources 
that are expected to provide these services will, in turn, be depleted by the 
epidemic (Whiteside & Sunter, 2002: 67).   
 
 
2.3   CURRENT STATUS OF THE PANDEMIC IN SOUTH AFRICA 
 
There are a number of predisposing factors that have made and continue 
to make South Africans susceptible to a particularly severe pandemic.  
Nattrass (2004: 34) mentions the following: 
 
• Established epidemics of other sexually transmitted diseases 
(STDs).  These act to increase the likelihood of transmission of HIV; 
• Disrupted family and communal life, due in part to apartheid, 
migrant labour patterns and high levels of poverty in the region; 
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• Good transport infrastructure and high mobility, allowing for rapid 
movement of the virus into new communities; 
• Resistance to the use of condoms, based on cultural and social 
norms; 
• The low status of women in society and within relationships.  
Economic dependency and the threat of physical force, in 
particular, make it difficult for women to protect themselves from 
infection; 
• Social norms that accept or encourage high numbers of sexual 
partners, especially amongst men; and 
• Parallel norms that frown on open discussion of sexual matters, 
including sex education for children and teenagers. 
 
 
The Second King Report on Corporate Governance (2002) notes that 
there is little evidence of measures taken by the corporate community to 
promote business sustainability in the face of the disease.  The report 
goes beyond broad guidelines and urges Boards of directors to take the 
following specific action:  
• Ensure that it understands the social and economic impact that 
HIV/AIDS will have on business activities; 
• Adopt an appropriate HIV/AIDS strategy, plan and policies to 
address and manage the potential impact; 
• Regularly monitor and measure performance using established 
indicators; and 
• Report to stakeholders on a regular basis. 
 
Directors will need to obtain a clear understanding of their risk 
environment and to put a financial value to the potential impact of the 
disease on their business in order to develop a response that will enable 
them to comply with these requirements. 
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2.4   THE IMPACT OF HIV/AIDS AT THE WORKPLACE 
 
The HIV/AIDS epidemic primarily affects working-age adults and far 
exceeds any other threat to the health and well being of South African 
employees.  Although data on infection levels in the workforce in South 
Africa is scarce, and workforce profiles may change, over the next decade 
the number of employees lost to AIDS in SA could be the equivalent of 40 
to 50 per cent of the current workforce in some companies 
(UNAIDS/WHO, 2002).  
 
 At the level of individual businesses, HIV/AIDS among managers, 
employees and their families will impose significant direct and indirect 
costs.  Love Life (2003: 13) states that recent research indicates that each 
HIV infection is likely to cost companies between 1 and 6 times the 
employee’s annual salary, depending on the company’s benefit structure.   
 
According to Barnett and Whiteside (2002: 242) HIV/AIDS raises costs, 
reduces the productivity of individual workers and alters the firm’s 
operating environment through: 
• Increased absenteeism, the result of employee ill health or because 
staff, particularly woman, take time off to care for sick members of 
their families or because funeral ceremonies are frequent and time 
consuming; 
• Falling productivity:  workers whose physical or emotional health is 
failing will be less productive and unable to carry out more 
demanding jobs; 
• Employees who retire on medical grounds or who die have to be 
replaced and their replacements may be less skilled and 
experienced; 
• Recruitment and training of replacement workers incurs costs for an 
organisation; 
  18
• Employers may increase the size of the workforce and hence 
payroll costs to cover for absenteeism; 
• As skilled workers become scarcer, wage rates may increase; and 
• The business environment may change with investors reluctant to 
commit funds if they think AIDS and its impact will compromise their 
investments and returns. 
 
2.4.1 Absenteeism 
 
Work in the early 1990s by Roberts, Rau and Emery (1996) suggests that 
the greatest problem confronting companies is absenteeism.  HIV-related 
absenteeism accounted for 37% of increased labour costs, and AIDS 
absenteeism accounted for a further 15%. 
 
Recruitment
9% Health care
5%
Burial
16%
HIV absenteeism
37%
AIDS absenteesism
15%
Funeral attendance
6%
Labour turnover
5%
Training
7%
Fig 2.1   Distribution of increased labour costs due to HIV/AIDS by                       
               category. 
Source:  Roberts et al. (1996). 
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2.4.2 Cost of the pandemic 
 
The vulnerability of business to HIV/AIDS will vary, depending on factors 
such as the type of business and production processes.  Labour-intensive 
firms may appear to be at higher risk of lost production, but the actual 
impact will depend on the ease with which employees can be substituted.  
For a high skill, labour intensive industry it will be costly to train 
replacement staff, whereas low-skill industries such as commercial 
cleaning will be easily able to find replacement employees even at the 
height of the epidemic (UNAIDS, 2000). 
 
Other factors influencing the overall costs of the epidemic include the risk 
profile of employees, risk modification attempts by some companies, and 
the degree to which work processes have been planned to take HIV 
infection into account (UNAIDS, 2000). 
 
Over time, the costs of HIV/AIDS for most businesses will be substantial, 
and could affect international competitiveness. 
 
The Daily Dispatch (14/7/04) reports that according to the International 
Labour Organisation (ILO), the HIV/AIDS pandemic ravaging South Africa 
cost the economy more than $70 billion in the 10 years to 2002. 
 
“South Africa lost a staggering $72bn (about R440bn) between 1992 and 
2002 mainly due to deaths, absenteeism and lower productivity.  HIV/AIDS 
destroys the human capital built up over years and weakens the capacity 
of workers to produce goods and services for the economy”. 
 
Aids activists say an estimated 600 people die every day of the disease in 
South Africa, where HIV affects one in nine people, or 5,3 million, one of 
the highest rates in the world. 
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The ILO said the direct costs of the pandemic included expanded 
employee benefit packages to support dependents of sufferers or those 
who cannot work due to ill-health.  Fresh recruitment and the training of 
new employees was an additional strain. 
 
The Daily Dispatch (14/07/04) further reports that a survey conducted by 
the South African Business Coalition on HIV/AIDS (Sabcoha) of more than 
1 000 companies found that nine percent of them had felt the impact of 
HIV/AIDS on their business.  Nearly one in five companies surveyed by 
Sabcoha indicated that they foresaw appointing extra employees to 
compensate for the impact of HIV/AIDS on labour productivity, 
absenteeism and mortality. 
 
2.4.3   Responses to HIV/AIDS 
 
Much of the efforts of social scientists over the past 15 years have been 
directed at understanding the costs to the society of the AIDS epidemic. 
Impacts are usually compared to a ‘no-AIDS’ scenario and the difference 
is understood to be the impact of the epidemic.  This kind of analysis  has 
typically failed to take into account the responses of the society to the 
pandemic, in modelling impact and in determining the costs to the society.   
 
Rosen, Vincent, Simon, Singh & Thea (2000) propose investment in AIDS 
as good business practice, arguing that costs of prevention programmes 
are recovered by savings in terms of costs to the company of the 
pandemic.   AIDS ultimately costs the company less when resources are 
committed to responding to it.  We cannot understand the impact of AIDS 
on the economy until we understand the nature and scope of responses to 
it. 
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2.5   METHODS FOR DESCRIBING THE IMPACT OF HIV/AIDS 
 
Private sector activities are profit driven.  Private enterprise does not 
provide welfare services, although most large companies recognise the 
relation between employee satisfaction and provision of benefits.  Senior 
managers have to address the following: 
• What is the effect of this disease? 
• How do we measure it? 
• What can we do about it? 
 
Companies respond both to studies and to their own perception of the 
pandemic.  Companies are not passive.  Because they are profit-focused 
and competing, and because they have resources, they are able to and 
willing to commission impact studies.  The findings of these studies 
become the ‘reality’ within which the company makes strategic decisions. 
 
The general approach as outlined by Barnett and Whiteside (2002: 251) 
takes the following three components into account: 
 
1.  direct costs – impacts that involve increased financial outlays by the       
     company; 
2.  indirect costs – reduced workforce productivity less output for a given   
level of expenditure on labour, including reduced productivity by both 
the infected employee and by other employees who are diverted from 
their normal responsibilities; 
3.  systematic costs – resulting from cumulative impact of multiple       
      HIV/AIDS cases. 
 
The method for completing such a study is summarised in Fig 2.2 and  
Fig 2.3.   
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These are taken from a methodology developed by staff of the Harvard 
Institute of International Development (Simon, Rosen, Whiteside, Vincent 
& Thea, 2000).  It shows how, through a number of discrete accounting 
steps, it is possible to arrive at an estimate of the workforce-related costs 
of the epidemic. 
 
 
Fig 2.2    Progression of cases and costs of workforce HIV/AIDS. 
Source:   Simon et al. (2000).   
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Fig 2.3    Economic impact on the workforce of HIV/AIDS. 
Source:   Simon et al. (2000). 
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Estimating aggregate costs in all three categories requires three other 
critical pieces of information (Parker et al, 2000): 
 
First, HIV/AIDS prevalence, morbidity, and mortality must be measured. 
 
Second, because HIV infection rates tend to vary with age, sex, race, 
geographic location within South Africa and by job level, a detailed 
demographic profile of the current and future workforce is critical to the 
analysis. 
 
Finally, certain positions and skills are vital to a company’s core 
processes.  If such positions are vacant, the ability to provide the product 
or service will be heavily or completely impaired.  These critical positions 
and skills have to be identified upfront and the people filling them carefully 
monitored for illness. 
 
Once all the potential influences that HIV/AIDS could have on a 
company’s internal and external environment have been ascertained, 
suitable responses to the challenge have to be formulated.  According to 
Whiteside and Sunter (2002: 113) these fall into four areas: 
 
• The impact on production and employees; 
• The impact on cost; 
• The impact on markets; and 
• Business in society. 
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2.6   MANAGEMENT OF HIV/AIDS IN THE WORKPLACE 
 
The code of good practice on Aspects of HIV/Aids Employment 
(www.ccma.org.za: 2004) advise as follows on the Management of HIV in 
the workplace: 
 
The effective management of HIV/AIDS in the workplace requires an 
integrated strategy that includes, amongst others, the following elements: 
i) An understanding and assessment of the impact of HIV/AIDS on 
the workplace; 
ii) Long and short term measures to deal with and reduce this 
impact, including: 
 
• An HIV/AIDS policy for the workplace 
• HIV/AIDS programmes, which would incorporate: 
 
a.  Ongoing sustained prevention of the spread of HIV                               
        among employees and their communities; 
b. Management of employees with HIV so that they are able 
to work productively or as long as possible; and 
c. Strategies to deal with the direct and indirect costs of 
HIV/AIDS in the workplace. 
 
 
2.6.1 HIV/AIDS Policy for the Workplace 
 
 Every workplace should develop an HIV/AIDS policy, in order to ensure 
that employees affected by HIV/AIDS are not unfairly discriminated 
against in employment policies and practices.  
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This policy should cover (www.ccma.org.za: 2004): 
 
(i)   the organisation’s position on HIV/AIDS; 
(ii)   an outline of the HIV/AIDS programme; 
(iii)   details on employment policies (e.g. position regarding HIV testing); 
(iv)   express standards of behaviour expected of employers and    
        employees and appropriate measures to deal with deviations from                  
        these standards; 
(v)   grievance procedures; 
(vi)   set out the means of communication within the organisation on  
          HIV/AIDS issues; 
(vii)   details of employee assistance available to persons affected by 
HIV/AIDS; 
(viii)   details of implementation and coordination responsibilities; and 
(ix)   monitoring and evaluation mechanisms. 
 
 
2.6.2 HIV/AIDS Workplace Programmes 
 
It is recommended that every workplace works towards developing and 
implementing a workplace HIV/AIDS programme aimed at preventing new 
infections, providing care and support for employees who are infected or 
affected, and managing the impact of the epidemic in the organisation. 
 
Every workplace programme should attempt to address the following in 
cooperation with local, provincial and national initiatives 
(www.ccma.org.za: 2004): 
 
(i) hold regular HIV/AIDS awareness programmes; 
(ii)  encourage voluntary testing; 
(iii)  conduct education and training on HIV/AIDS; 
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(iv)  promote condom distribution and use; 
(v) encourage health seeking behaviour for STD’s; 
(vi)  enforce the use of universal infection control measures; 
(vii)  create an environment that is conducive to openness, disclosure 
and acceptance amongst all staff;  
(viii)  endeavour to establish a wellness programme for employees 
affected by HIV/AIDS; 
(ix)  provide access to counselling and other forms of social support for 
people affected by HIV/AIDS; 
(x)  maximise the performance of affected employees through 
reasonable accommodation, such as investigations into alternative 
sick leave allocation; 
(xi)  develop strategies to address direct and indirect costs associated 
with HIV/AIDS in the workplace; and 
(xii)  regularly monitor, evaluate and review the programme. 
 
 
2.7 CONCLUSION 
 
This concludes Chapter 2, which introduced selected theory and findings 
of other researchers in respect of HIV/AIDS and its impact at the 
workplace. 
 
Chapter 3 deals with the response of DaimlerChrysler South Africa 
(DCSA) to the HIV/AIDS pandemic.  DCSA initiated a review of its 
HIV/AIDS response in 2000.  In association with GTZ (Deutsche 
Gesellschaft fur Technische Zusammenarbeit), the Technical Cooperation 
Agency of the German  Ministry of Economic Cooperation and 
Development, the company has developed a comprehensive HIV/AIDS 
programme.  
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CHAPTER 3 
 
ADDRESSING HIV/AIDS AT DAIMLERCHRYSLER SOUTH AFRICA 
 
 
3.1 INTRODUCTION 
 
Managing HIV/AIDS is core business for DaimlerChrysler South Africa 
(DCSA).  The HIV/AIDS Workplace Programme of the DaimlerChrysler 
Group of Companies in South Africa aims at effectively addressing the  
challenge posed by HIV/AIDS to DaimlerChrysler employees, their 
families, business operations, and economic and social development more 
broadly (www.daimlerchrysler.com: 2004). 
 
The DaimlerChrysler Workplace Programme strives to: 
• Extend quality prevention, treatment, care and support to 
employees, their dependants and the community; 
• Reflect the corporation’s commitment to Corporate Social 
Responsibility; and 
• Progressively manage the increasing financial and human 
resources management impacts associated with HIV/AIDS 
(www.hivaids.daimlerchrysler.co.za: 2004). 
 
3.2 THE COMPANY 
 
DaimlerChrysler is one of the world’s leading automotive, transportation 
and service companies with a global workforce, a global shareholder base, 
a global brand awareness and a global outlook.   
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DaimlerChrysler’s strategy rests on four pillars:  Global Presence, Strong 
Brands, Broad Product Range and Technology Leadership 
(www.businessfightsaids.org: 2004). 
 
DaimlerChrysler South Africa (DCSA) has three main plants that 
manufacture, market, import and export motor vehicles and automotive 
parts.  East London is their largest facility with 79% of the workforce 
(www.weforum.org: 2004).  In 2001, DCSA had 4,500 employees and  
3,000 suppliers and contractors working at these three facilities.  Although 
not part of the workplace and community projects, DCSA indirectly impacts 
2,900 other workers who are members of other DaimlerChrysler affiliates 
or employed as part of the dealer network (www.unaids.org: 2004).  The 
company manufactures Mercedes-Benz passenger cars and Mitsubishi 
pick-ups for the South African market and exports to the UK, Japan and 
Australia.  The HIV/AIDS program covers its employees and their families, 
a total of 23,000 people (www.daimlerchrysler.com: 2004).  
 
 
3.3 HIV/AIDS IS A WORKPLACE ISSUE 
 
HIV/AIDS is a workplace issue because it predominantly affects working 
people and because the workplace has a vital role to play in limiting the 
spread and effects of the pandemic.   
 
The impacts of HIV/AIDS at DaimlerChrysler South Africa can be broadly 
categorised as (www.hivaids.daimlerchrysler.co.za: 2004): 
 
(a) Direct impacts; 
(b) Indirect impacts; and 
(c) Systemic impacts. 
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3.3.1 Direct Impacts at DCSA 
• Costs of workplace programs; 
• Health care costs; and 
• Costs of disability and death benefits. 
 
3.3.2 Indirect Impacts at DCSA 
• Costs associated with incapacity; 
• Costs of increased absenteeism; 
• Costs associated with premature loss due to disability and death; 
• These manifest as: 
- diversion of  management resources; 
- productivity and output losses; and  
- recruitment and retraining costs. 
 
3.3.3 Systematic Impacts at DCSA 
• Costs associated with rising disease burden; 
• Costs associated with impacts on the market; 
• Very difficult to plan adequately for these costs; 
• These include: 
- workplace stress; 
- impacts on organisational culture; 
- impacts on morale and cohesion; and 
- impacts on sustainability of the business. 
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3.4      SITUATION ANALYSIS 
 
A study was undertaken in 2001 to estimate the proportion of DCSA 
employees that are infected with HIV and to determine which demographic 
variables may be associated with HIV infection.  The results from this 
study were used to make projections on future HIV prevalence levels, to 
estimate the economic and other impacts of HIV on the company and as a 
baseline against which to evaluate the DCSA HIV/AIDS programme in 
future (www.businessfightsaids.org). 
 
 
 
 
 
 
 
Fig 3.1   Projected prevalence of HIV in DCSA from 1985 to 2015. 
Source:  DCSA internal report. 
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Fig 3.3   Economic impact study – structure by costs of all new HIV         
     Infections within DCSA in 2001. 
Source:  DCSA internal 2002 economic impact study. 
 
 
3.4.1 Economic Impact 
 
Regarding the expected economic impact of its program, DCSA  
commissioned a scientific study in 2002, with the following findings  
(DCSA internal analysis of the economic impact of HIV/AIDS:  
www.daimlerchrysler.co.za: 2004): 
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• According to the study, the present value of all new HIV infections 
in DCSA in the year 2001 alone is estimated at R 9,340,000.  
Considering the period from 2001 to 2011, the total present value of 
all expected new HIV infections is estimated at about R 70,000,000. 
• For hourly paid employees, the present value of one new HIV 
infection is estimated at R 166,000, for salary band A at R 265,000, 
for salary band B at R 615,000, for salary bands C and D at R 
1,364,000 on average. 
• Based on the composition of the workforce, the average present 
value (2002) of one new HIV infection is R 342,110.   
• The study’s authors argue that DCSA can achieve an additional 
positive economic effect by providing treatment and care that keep 
HIV positive employees in the workforce longer, thereby delaying 
costs further into the future.  Extending the average period from HIV 
infection to death from AIDS from nine to ten years would reduce 
the total cost to DCSA by 10 per cent.  Provided that the increase in 
live expectancy can be achieved at less than 10 per cent of the cost 
in the “no treatment” scenario, investments in treatment and care 
will also have a positive financial return.  Given the substantial 
impact of Antiretroviral Treatment (ART) on workers’ health and life 
expectancy, and falling costs for ART medicine, this argument 
suggests a positive impact on the bottom line of the program. 
 
The study concludes that investment in prevention and treatment is 
potentially attractive (www.daimlerchrysler.co.za: 2004). 
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3.5      DCSA HIV/AIDS WORKPLACE POLICY  
 
The cornerstone of the DCSA HIV/AIDS project is its policy on HIV/AIDS.  
DCSA first codified its HIV/AIDS workforce policy in 1996.The policy is 
updated annually in the first quarter of every year.  Each version is signed 
and approved by the union and management (www.redribbon.co.za: 
2004). 
 
3.5.1 Purpose 
 
The purpose of the HIV/AIDS Workplace policy is to ensure a uniform and 
fair approach to the effective prevention of HIV/AIDS amongst employees 
and their families and access to comprehensive care, support and 
treatment for employees and their dependants living with HIV/AIDS 
(www.hivaids.daimlerchrysler.co.za: 2004). 
 
3.5.2 Principles 
 
The DaimlerChrysler HIV/AIDS Workplace policy was developed with the 
underpinnig principles of consultation with DCSA employees at all levels, 
equity to employees living with HIV/AIDS, confidentiality, rights and 
responsibilities and disciplinary and grievance procedures for breaches in 
the policy (www.hivaids.daimlerchrysler.co.za: 2004). 
 
In creating a non-discriminatory and caring environment, the policy  
addresses (www.weforum.org: 2004): 
 
• Stigma and discrimination; 
• Counselling and testing; 
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• Confidentiality and disclosure; 
• Performance management; and 
• Occupational health and safety. 
 
See Annexure 1 for DCSA HIV/AIDS Workplace Policy. 
 
 
3.6      DCSA HIV/AIDS WORKPLACE PROJECT 
 
It is estimated that 6 million South Africans are infected with HIV (13 – 15 
per cent prevalence).  The average HIV prevalence in DaimlerChrysler 
South Africa in 2001 was 9 per cent (East London plant 10 per cent).  
HIV/AIDS mortality in DCSA was expected to peak in 2006 without further 
successful interventions (www.daimlerchrysler.com: 2004).   
 
 
3.6.1   GTZ/DCSA HIV/AIDS Project 
 
Recognizing the dynamics of the HIV/AIDS pandemic in South Africa and 
the increasing impact on the company, DCSA realised in 2000 its need to 
optimise and modernise its strategic approach to HIV/AIDS. In order to 
ensure a world-class, comprehensive and needs-oriented approach to 
HIV/AIDS, a partnership between DCSA and the German Technical 
Cooperation (GTZ) was forged in November 2000 (www.gtz.de: 2004). 
 
The planning and implementation of the HIV/AIDS programme at DCSA 
has since been a joint effort between the GTZ and DCSA.  This effective 
collaboration was enabled through the Public Private Partnership (PPP) 
Programme of the German Federal Ministry of Economic Cooperation and 
Development (BMZ) (www.businessfightsaids.org: 2004). 
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 The Company’s HIV/AIDS programme  was developed with the aid of 
demographic profiling of the workforce.  The package covers 
(www.hivaids.daimlerchrysler.co.za: 2004): 
 
• Information, education and communication, including the use of 
trained peer educators to address discrimination as well as HIV 
transmission; 
• Condom availability and distribution; 
• Voluntary counselling and testing (VCT); and 
• An integral disease management protocol extending the existing 
medical scheme to cover treatment of opportunistic infections, 
sexually transmitted infections (STIs), short course antiretroviral 
therapy (ARVs) for prevention of vertical transmission, ARV 
treatment, monitoring and hospitalisation 
(The Global Business Council on HIV/AIDS, 2002). 
 
 
An appropriate management system, including comprehensive monitoring 
and evaluation, was established to ensure that the activities of HIV/AIDS 
Workplace Project are integrated as core business in DCSA. 
 
The DCSA/PPP HIV/AIDS Workplace Project cost approximately R500.00 
per employee per annum spent on prevention, care and support initiatives 
at all business locations and in immediate communities.  HIV/AIDS 
treatment costs (including cost of anti-retroviral drugs) currently average at 
R17, 000.00 per infected employee or family member per annum 
(www.hivaids.daimlerchrysler.co.za: 2004). 
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3.6.2 Strategy 
 
The strategies that have been adopted by DCSA/PPP to achieve their goal 
are: 
 
• To effectively address the development challenge posed by 
HIV/AIDS to the emerging economy; 
• To address increasing financial and management burden 
associated with HIV/AIDS; 
• To extend quality prevention, treatment, care and support services 
to employees, their dependants and the community; and 
• To reflect DaimlerChrysler’s Corporate Social Responsibility 
strategy (www.daimlerchrysler.com: 2004). 
 
 
3.6.3 Objectives 
 
The objectives of the DCSA/PPP HIV/AIDS Workplace Project are: 
 
To establish a policy-driven, sustainable and comprehensive HIV/AIDS 
workplace program that (www.weforum.org: 2004): 
 
• Prevents further infection and reduces stigmatization; 
• Reduces severity and frequency of HIV related disease through a 
health promotion and comprehensive health care approach; 
• Ensure appropriate human resources management, management 
of employee benefits and management of operational impacts; and 
• Enable appropriate advocacy and community involvement 
initiatives.  
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3.6.4 DCSA/PPP HIV/AIDS Workplace Project Components 
 
The Workplace Project comprises of four components: 
   
I. Information, Education and Communication; 
II. Integrated Health Care;  
III. Risk Management; and 
IV. Community Involvement and Advocacy. 
 
Each component is discussed below. 
 
Information, Education and Communication  
This component comprises continuous and strategic HIV and AIDS 
awareness, education and prevention activities integrated into the 
ongoing communication, education and training activities of DCSA.  
This is centred on the “Peer Educator Approach” and complemented 
by formal training of a range of employee strata, periodic HIV/AIDS 
campaigns and comprehensive utilisation of existing communication 
tools (www.daimlerchrysler.com: 2004).   
 
Integrated Health Care 
This component comprises improvement of existing employee health 
care benefits to adequately meet the impact of the HIV/AIDS epidemic.  
This applies to both in-house occupational health services and benefits 
provided through the company medical aid.  A comprehensive health 
care approach is used to ensure that the HIV/AIDS Programme is 
integrated into employee wellness and employee assistance initiatives.  
Particular attention is paid to enhancing services for voluntary 
counselling and testing (VCT) and proper treatment of sexually 
transmitted diseases (STDs).  Ongoing access to standard treatment 
regimens for opportunistic diseases and anti-retroviral medication will  
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be funded through the Medical Aid scheme.  Protocol and procedures 
for these benefits are managed by Medscheme’s Aid for AIDS 
Programme (www.aidforaids.co.za: 2004). 
 
Risk Management 
This component involves the review and re-organisation of insured 
employee benefits, human resource development and organisational 
development plans to minimize the effect of HIV/AIDS related 
absenteeism, labour turnover, reduced productivity, disability and 
death. 
 
Community Involvement and Advocacy 
This component entails the extension of the DCSA HIV/AIDS 
Programme into the communities where DCSA employees live.  The 
focus is on support to community-based HIV/AIDS initiatives and 
advocacy (www.daimlerchrysler.com: 2004). 
 
 
3.6.5   Anticipated Results 
 
The results expected from the implementation of the above-described 
components have been formulated as follows (www.weforum.org: 2004): 
 
1. Increased effectiveness of DCSA Health Services related to 
HIV/AIDS prevention and care. 
2. Ensured adequate and cost-effective benefits in order to meet 
employee’s needs in the HIV prevalent environment while 
minimizing the cost of HIV/AIDS impact on DCSA operational 
activity. 
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3. Increased information, education and communication about       
HIV/AIDS and new services at DCSA among all employees in order 
to decrease stigma and increase preventive and care seeking 
behaviours (www.hivaids.daimlerchrysler.co.za: 2004). 
 
 
3.7   CONCLUSION 
 
This concludes Chapter 3, DaimlerChrysler South Africa’s response to the 
HIV/AIDS pandemic.  DCSA established its workplace and community 
HIV/AIDS project to address the increasing financial burden associated 
with HIV/AIDS.  DCSA provide prevention, care, support and treatment 
services to employees, their dependants and the community as part of 
DCSA’s obligation to these stakeholders based on the principles of 
corporate social responsibility (www.weforum.org: 2004). 
 
The next chapter deals with the Research Design and Methodology 
adopted to solve the main problem of this Research Paper viz.  
“How effective is DCSA in addressing the HIV/AIDS pandemic?”  
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CHAPTER  4 
 
DESIGNING THE EMPIRICAL SURVEY 
 
 
4.1   INTRODUCTION 
 
DaimlerChrysler South Africa has implemented strategies to limit the 
impact and consequences of the HIV/AIDS pandemic on its workers, their 
families and surrounding communities through its HIV/AIDS Workplace 
Project. 
 
This chapter presents the design of a survey intended to gather 
information on the attitude and perception of DCSA employees regarding 
HIV/AIDS at the workplace.   
 
The aim of this research paper is to gain knowledge from results of the 
survey, which can be used to continuously improve the DCSA HIV/AIDS 
Workplace Programme. 
 
 
4.2   THE RESEARCH DESIGN 
 
The object of the empirical study was to identify how effectively the 
pandemic is being addressed at DCSA.  The empirical study consisted of 
a research instrument which was developed for the purpose.  The 
indicators and variables included in the questionnaire were selected in 
consultation with the relevant stakeholders and health care professionals 
at DCSA. 
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A survey is quite simple in design:  The researcher poses a series of 
questions to willing participants; summarizes their responses with 
percentages, frequency counts, or more sophisticated statistical indexes; 
and then draws inferences about a particular population from the 
responses of the sample (Leedy & Ormrod, 1985:196). 
 
In order to execute the aims of the survey, a Research Design comprising 
the following activities was followed: 
 
a. Defining the sample; 
b. Developing the research instrument; 
c. Administering the survey; 
d. Capturing and interpreting the data; and 
e.   Reporting on the findings. 
 
 
 4.3   DEFINING THE SAMPLE 
 
The study was conducted on a random sample of 50 employees.  The 
sample was selected from across various job bands in DCSA and was 
stratified by job grade into the following 3 strata: 
 
• 30 Hourly paid employees  (i.e. all plant and service support 
employees);  
• 10 Management  (both senior and middle management i.e. job 
grades 1 – 5); 
• 10 Administrative  (job grades 6 – 8). 
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4.4   DEVELOPING THE RESEARCH INSTRUMENT   
 
The questionnaire was tailored to the intended audience at DCSA  
East London.  The survey included a range of fixed-choice and some 
qualitative questions which were used to interpret the findings. 
The questionnaire was customised to the DCSA context and included 
DCSA-specific questions pertaining to the DCSA HIV/AIDS Workplace 
Project.  
 
4.4.1   Designing the instrument 
 
It was necessary for the researcher to conduct an extensive desk study 
investigating other comparable surveys.  The body of literature was 
reviewed and a wide range of literature pertaining to HIV/AIDS and 
DaimlerChrysler South Africa was consulted in the process of 
development.  Informed by the literature and the consultations within 
DCSA, a draft questionnaire was developed.  Thereafter it was discussed 
with relevant stakeholders within DCSA and amendments to the 
questionnaire were incorporated. 
 
The researcher was requested to attend a Site Human Resources meeting 
at DCSA in East London to make a power point presentation to Site 
Leadership on the proposed research project and the survey methodology 
to be used.  
 
See Annexure 2 for Power Point Presentation:   
DCX-SA (EL) HIV/AIDS QUESTIONNAIRE 
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The survey was intended to gather information pertaining to:   
 
• The biographical data of the selected respondents; 
• Their knowledge regarding HIV/AIDS; and 
• Their attitude and perception towards the different aspects of the 
DCSA HIV/AIDS Workplace Project. 
 
For the purpose of this survey, the instrument is also intended to gather 
data on the extent of the impact of HIV/AIDS interventions within DCSA 
and within the communities from which the workforce is drawn. 
 
The questionnaire comprised a range of fixed-choice questions and some 
qualitative questions.  The qualitative questions were intended to allow the 
respondent to reflect and give answers free of the limitations and 
constraints which are established by the researcher’s asking questions 
whose answers are pre-framed.  All fixed-choice questions have the 
disadvantage of limiting the respondents’ response to selecting one of 
approximately 3 to 5 of the researcher’s pre-given answers.   
 
Through using qualitative questions, respondents were encouraged to 
relate, in their own terms, experiences and attitudes that are relevant to 
the issues under investigation.  This approach affords researchers the 
opportunity to probe and to explore dimensions of the areas under 
investigation.  By way of the qualitative questions, respondent’s answers 
are not restricted to a few pre-framed answers which the researcher might 
have thought were important.  Rather, the interviewee is given an 
opportunity to give expression to a variety of ideas and to talk about the 
meanings and experiences of matters of relevance. 
 
While this approach does not lend itself to easy quantification it allows the 
researcher an opportunity to gather data that is far richer and more varied 
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than is possible with a conventional survey approach.  The kinds of data 
that were obtained using qualitative methods answered the following 
questions: 
 
• Your comments or suggestions regarding the DCSA HIV/AIDS 
Workplace Project; 
• Your comments or suggestions regarding Occupational Health 
Services (OHS) and Voluntary Counselling and Testing (VCT); 
• Your comments or suggestions regarding the role of peer 
educators; 
• Your comments or suggestions regarding stigma attached to 
HIV/AIDS; 
• What more do you think DCSA can do to help prevent the spread 
of HIV/AIDS? and 
• What more do you think DCSA can do to support people affected 
by HIV/AIDS? 
 
4.4.2   Questionnaire 
 
The questionnaire can be viewed in Annexure 3. 
 
DCX-SA (East London) HIV/AIDS QUESTIONNAIRE - July 2004 
 
Section A Biographical information 
Section B Part 1  -  “Your understanding of HIV/AIDS” 
  Part 2  -  “Your opinion” 
 
The focus of the questionnaire is on the employees’ perception and 
attitude regarding the different aspects of the DCSA Workplace Project. 
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Advantages of the questionnaire as research method: 
 
• Awareness amongst East London employees of the DCSA 
HIV/AIDS Workplace programme; and 
• Employees can respond to questions with the assurance that their 
responses will be anonymous, and so they may be more truthful 
than they would be in a personal interview, particularly when they 
are talking about controversial issues. 
 
   
4.4.3   Objectives of the survey  
 
The specific objectives of this survey were to identify: 
 
• How effective is DCSA in addressing the HIV/AIDS pandemic; 
• Employees’ attitude and perception regarding the impact of 
HIV/AIDS at the workplace; 
• The attitude and perception employees have regarding different 
aspects of the DCSA Workplace Project;  
• The difference among employees of different job bands, age, race, 
gender and qualification with regard to the above information; and 
• Employees’ understanding of HIV/AIDS as a variable to compare 
with their perception and attitude regarding the DCSA Workplace 
Project. 
 
4.4.4   Limitations of the research approach 
 
The research process for this study is typical of survey studies in general 
where the respondents are asked questions which they are required to 
answer.  While the survey approach is a suitable method used to gather  
information, there are problems associated with this method: 
  47
• Respondents in studies which deal with sensitive topics may 
believe that the information will be used against them.  For this 
reason, respondents often give normative answers based on what 
they think they should answer; 
• The survey approach limits the responses of the respondents to 
selecting from a handful of predetermined responses.  It does not 
allow the respondent the latitude to give an answer which is not 
predetermined by the researcher; 
•  It is also likely, given the emphasis on one’s rights to privacy in the 
context of HIV/AIDS research, that the survey may be considered 
an invasion of a respondent’s rights to privacy; and 
• Respondents may feel that their answers will reveal their stupidity 
and they may therefore be reluctant to answer, making it imperative 
that the researcher informs the respondent that there are no right or 
wrong answers. 
 
In order to allay the kinds of fears referred to above, it was imperative in 
this study that the researcher assured respondents of their anonymity. 
 
4.4.5   Informing respondents  
 
It was essential that a large portion of the time allocated for the 
questionnaire was spent developing rapport and that the researcher 
explained the research context, in order to get the cooperation of the 
respondents.  The following needed to be explained to the respondents: 
 
• The random nature of the sample; 
• That respondents’ participation was “voluntary”; 
• That the survey was confidential and anonymous; and 
• How the survey data would be treated. 
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4.5   ADMINISTERING THE QUESTIONNAIRE 
 
All the questionnaires were administered by the researcher at the various 
sites at DCSA in East London.  Due to the nature of the company, the 
survey needed to be scheduled in such a way that there was minimal 
impact on the production processes.   
 
The responsibility for negotiating the administration of the survey with 
Departmental Supervisors rested with DCSA.  A coordinator was 
appointed by DCSA to arrange and coordinate the scheduling of the 
survey with employees of different job bands at the various sites.  It was 
also necessary that DCSA communicated to all personnel that the survey 
was being conducted. 
 
The researcher distributed the questionnaires to the respondents, who 
completed the survey on their own and deposited the completed 
questionnaires into a sealed box.  It took respondents approximately 30 
minutes to complete the questionnaire. 
 
 
4.6   CAPTURING, ANALYSING AND INTERPRETING THE DATA 
 
It was necessary that respondents were able to observe that their 
completed questionnaires were treated with confidentiality. The completed 
questionnaires were deposited into a sealed box.  The surveys were  
opened off site where they were sent for data capturing. 
 
The data was coded, entered and processed.  The statistical procedures 
to be used in interpreting and analysing the data was determined in 
consultation with a statistician. 
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Basic frequencies were presented in order to determine patterns that may 
emerge from the data.  Correlations as are indicated in the findings of this  
report were made.     
 
 
4.7   CONCLUSION 
 
This concludes Chapter 4, the design of the empirical study, which details 
the research methodology used to achieve the objectives of this survey.  
 
The next chapter will be the final step in the research design to execute 
the aim of the survey:  Reporting on the findings.  This chapter will be a 
collation of the main findings from this research project. 
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CHAPTER 5 
 
RESULTS OF THE EMPIRICAL STUDY 
 
 
5.1 INTRODUCTION 
 
In Chapter 4 the data that was needed to fulfil the objective of this 
research was identified.  The research instrument that was used to collect 
that information was also identified and where necessary clarified.  After 
the questionnaire had been prepared and administered, the data was 
collected.  In this chapter the results from the data collection process are 
presented.   
 
The following information represents the results of the DCX-SA (East 
London) HIV/AIDS Questionnaire July 2004: 
 
5.2 RESULTS OF SECTION A:   
BIOGRAPHICAL INFORMATION 
 
5.2.1 Age 
 
The ages of respondents are shown in the following table.  These may be 
compared with the actual age breakdown of employees at DCSA.  The 
total DCSA population  (www.weforum.org: 2004) shows the same 
breakdown as the sample viz. highest frequency in the 31 – 40 age group, 
followed by the 21 – 30 and 41 – 50 age groups.   Comparability and 
hence generalisability of the sample and the DCSA population is possible. 
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Table 5.1  Breakdown of sample by age 
Age    Frequency   Percent 
Under 20   0    0% 
21 – 30    14    28% 
31 – 40    19    38% 
41 – 50    12    24% 
51 – 60    5    10% 
61 and older   0    0% 
 
This same breakdown is shown in the Pie chart below. 
Breakdown of sample by age
0%
28%
38%
24%
10%
0%
under 20
21 - 30
31 - 40
41 - 50
51 - 60
61 and older
 
 
 
5.2.2 Gender 
 
A sample of 13 females and 37 males from the workforce completed the 
questionnaire.  A total of 572 females and 3873 males are employed by 
DCSA (www.weforum: 2004).  The number of female respondents in the 
sample constitutes 2.3 per cent of the total female population and the 
number of males represents approximately 1 per cent. 
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Table 5.2   Breakdown of sample by gender    
Gender   Frequency   Percent  
Male   37    74% 
Female   13    26% 
 
This same breakdown is shown in the Pie chart below. 
Breakdown of sample by gender
74%
26%
Male
Female
 
 
 
5.2.3 Race  
 
The sample comprised mainly black and white respondents, with 
respectively a 48 per cent and 34 per cent representation.  There is no 
Indian representation in this sample. 
 
Table 5.3   Breakdown of sample by race 
Race    Frequency   Percent 
Asian    1    2%   
Black    24    48% 
Coloured   8    16% 
Indian    0    0% 
White    17    34% 
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This same breakdown is shown in the Pie chart below. 
Breakdown of sample by race
2%
48%
16%
0%
34%
Asian
Black
Coloured
Indian
White
 
 
 
5.2.4 Highest Qualification 
 
Of the total number of respondents (50) who answered the questionnaire, 
only 1 did not attend high school.  The 48 per cent of respondents who 
indicated that they had completed high school suggest a well-educated 
workforce, as does the relatively high number (15 or 30 per cent) who 
have completed tertiary education.  Unfortunately “Diploma” was not 
specified as a 3 year qualification, hence the figure might be inflated.  
 
Table 5.4   Breakdown of sample by qualification 
Qualification  Frequency   Percent 
Primary School   1   2% 
High School – non Matric  8   16% 
High School – Matric  24   48% 
Diploma/Degree   15   30% 
Honours    0   0% 
Masters    2   4%    
 
 
 
  54
This same breakdown is shown in the Pie chart below. 
Breakdown of sample by qualification
2%
16%
48%
30%
0%
4%
Primary School
High School - non Matric
High School - Matric
Diploma/Degree
Honours
Masters
 
 
 
5.2.5 Years of service 
 
The sample indicates that most employees who completed the  
questionnaire have between 2 and 10 years of service at DCSA.   
Eighteen per cent of the respondents had been working for 15 or more 
years. 
 
Table 5.5   Breakdown of sample by years of service 
Years of service  Frequency   Percent 
0 – 1 year   1   2% 
2 – 5 years   15   30% 
6 – 11 years   19   38% 
11 – 15 years   6   12% 
15 or more years   9   18%  
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This same breakdown is shown in the Pie chart below. 
Breakdown of sample by years of service
2%
30%
38%
12%
18%
0 - 1 years
2 - 5 years
6 - 10 years
11 - 15 years
15 or more years
 
 
 
5.2.6 Employment level 
 
The total sample for this survey comprised 50 employees from DCSA East 
London.  The sample was stratified according to job grade and the survey 
required respondents to identify their employment level. 
 
Management:  The stratum of management in the questionnaire did not 
distinguish between middle and top management or between respondents 
who had a supervisory role and who perceived themselves to be 
managers.  Hence for the purpose of this survey, the management 
category comprises all employees from grades 1 to 5. 
 
Administrative:  There did not appear to be any confusion with the 
administrative category itemised in the questionnaire since this category is 
unambiguous.  This stratum comprised all respondents who were in job 
grades 6 to 8. 
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Hourly paid:  In terms of the three strata defined for this survey, it was 
necessary to include in this category all respondents who perceived 
themselves as being service workers or plant workers, as well as those 
who identified themselves as hourly workers.  
 
Table 5.6   Breakdown of sample by employment level 
Employment Level  Frequency  Percent 
Hourly paid employees  30   60% 
Management   10   20% 
Administrative   10   20% 
 
This same breakdown is shown in the Pie chart below. 
Breakdown of sample by employment level
60%20%
20%
Hourly paid
Management
Administrative
 
 
 
 
 
 
 
 
 
 
 
 
  57
5.3 RESULTS OF SECTION B  PART 1:   
“YOUR UNDERSTANDING OF HIV/AIDS” 
 
 
Table 5.7   Q 1:  Can AIDS be cured? 
    Frequency   Percent 
Yes    4    8%  
No    42    84% 
Not sure    4    8% 
 
The majority of respondents (84 per cent) correctly said that AIDS cannot 
be cured.  
 
Table 5.8   Q 2:  Is there a difference between HIV and AIDS? 
    Frequency   Percent 
Yes    40    80% 
No    8    16% 
Not sure    2    4% 
 
The majority of respondents (80 per cent) correctly said that there is a 
difference between HIV and AIDS. 
 
Table 5.9   Q 3:  Do Sexually transmitted Diseases (STD’s) increase             
                     your chance of contracting HIV?      
    Frequency   Percent 
Yes    49    98% 
No    0    0% 
Not sure    1    2% 
 
The vast majority of respondents (98 per cent) correctly said that Sexually 
Transmitted Diseases (STD’s) increase your chance of contracting HIV. 
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Table 5.10   Q 4:  Can HIV be cured if diagnosed early and treated?  
    Frequency   Percent 
Yes    13    26% 
No    32    64% 
Not sure    5    10%  
 
The proportion of correct answers to this question was much lower than in 
preceding questions.  Only approximately two-thirds correctly said that HIV 
cannot be cured, even if diagnosed early and treated.   
However, 26 per cent of respondents’ answers were incorrect and 10 per 
cent were not sure.  It is significant that just over one-third did not know 
the correct answer. 
 
Table 5.11   Q 5:  Can a person infected with HIV who is healthy still                        
                 transmit the virus to other people? 
    Frequency   Percent 
Yes    46    92% 
No    4    8% 
Not sure    0    0% 
 
The vast majority of respondents (92 per cent) correctly said that a person 
infected with HIV who is healthy can still transmit the virus to other people. 
 
Table 5.12   Q 6:  Is HIV spread only through sexual intercourse with                             
                             an infected person?  
    Frequency   Percent 
Yes    12    24% 
No    38    76% 
Not sure    0    0% 
 
The proportion of correct answers is lower than preceding questions.   
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Only 76 per cent of respondents correctly said that HIV is not only spread 
through sexual intercourse with an infected person.  It is significant that 24 
per cent of respondents did not know the correct answer. 
 
Table 5.13   Q 7:  Is it unsafe to work and live with a person who is    
                              HIV positive or who has AIDS? 
    Frequency   Percent 
Yes    7    14% 
No    42    84% 
Not sure    1    2% 
 
The majority of respondents (84 per cent) correctly said that it is not 
unsafe to work and live with a person who is HIV positive or who has 
AIDS. 
 
Table 5.14   Q 8:  Can HIV positive people remain an active part of  
                              society? 
    Frequency   Percent 
Yes    50    100% 
No    0    0% 
Not sure    0    0% 
 
All the respondents (100 per cent) correctly said that HIV positive people 
can remain an active part of society. 
 
 
Table 5.15   Q 9:  Do you think that anyone concerned about HIV       
                              should undergo a HIV test? 
    Frequency   Percent 
Yes    47    94% 
No    2    4% 
Not sure    1    2% 
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The vast majority of respondents (94 per cent) felt that anyone concerned 
about HIV should undergo a HIV test. 
 
Table 5.16   Q 10:  Do you know where to go for help if you think you                     
                                might be HIV positive? 
    Frequency   Percent 
Yes    47    94% 
No    0    0%    
Not sure    3    6% 
 
The vast majority of respondents (94 per cent) said that they knew where 
to go for help if they think they might be HIV positive. 
 
 
Summary:  Section B Part 1 
From the above results it is clear that the response to questions four and 
six should be noted: 
 
Question 4 Can HIV be cured if diagnosed early and treated? 
Thirty six per cent of respondents did not know the correct answer. 
 
Question 6 Is HIV spread only through sexual intercourse with an       
                      infected person? 
Twenty four per cent of respondents did not know the correct answer. 
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5.4 RESULTS OF SECTION B  PART 2:  
“YOUR OPINION” 
 
Q 1.1   I am aware of the DCSA Workplace policy on HIV/AIDS. 
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The vast majority of respondents (94 per cent) indicated that they were 
aware of the DCSA Workplace policy on HIV/AIDS. 
 
Q 1.2   The DCSA HIV/AIDS Workplace Project has enlightened me. 
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The vast majority of respondents (92 per cent) indicated that the DCSA 
HIV/AIDS Workplace Project had enlightened them. 
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Q 1.3   I believe DCSA is promoting HIV/AIDS awareness in a positive    
  manner. 
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The vast majority of respondents (96 per cent) indicated that they believe 
DCSA is promoting HIV/AIDS awareness in a positive manner. 
 
Q 2.1   I am confident that staff at Occupational Health Services  
            maintain confidentiality regarding employees’ HIV status. 
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The proportion of respondents that indicated that they were confident that 
staff at OHS maintain confidentiality regarding employees’ HIV status, was 
72 per cent.  It is significant that 28 per cent of respondents were either 
uncertain or disagreed with the above statement. 
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Q 2.2   I am aware of the positive benefits of knowing my HIV status. 
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The vast majority of respondents (96 per cent) indicated that they were 
aware of the positive benefits of knowing their HIV status. 
 
Q 2.3   I believe increasing Voluntary Counselling and Testing (VCT)      
            is a positive step forward in fighting the HIV/AIDS pandemic. 
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The vast majority of respondents (98 per cent) indicated that they believe 
increasing VCT is a positive step forward in fighting the HIV/AIDS 
pandemic. 
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Q 3.1   I understand what Antiretroviral treatment (ART) entails. 
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The proportion of respondents who indicated that they understood what 
ART entails, was 76 per cent.  It is significant that 24 per cent of 
respondents were uncertain or disagreed with the above statement. 
 
Q 3.2   I am aware of the benefits of ART and of joining AfA  
            (Aid for AIDS). 
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Seventy four per cent of respondents indicated that they were aware of the 
benefits of ART and of joining AfA.  It is significant that 26 per cent of 
respondents were uncertain or disagreed with the above statement. 
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Q 3.3   I feel that Antiretroviral Treatment should be available to all  
            employees.  
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The majority of respondents (90 per cent) indicated that they felt that ART 
should be available to all employees. 
 
Q 4.1   I am aware of the HIV/AIDS support and treatment offered to         
    HIV/AIDS employees and their families. 
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Sixty eight per cent of respondents indicated that they were aware of the 
HIV/AIDS support and treatment offered to HIV/AIDS employees and their 
families.  It is significant that 32 per cent of respondents were uncertain or 
disagreed with the above statement.  
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Q 4.2   I support the extension of HIV/AIDS prevention to dependants  
            of the workforce. 
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The vast majority of respondents (94 per cent) indicated that they 
supported the extension of HIV/AIDS prevention to dependants of the 
workforce. 
 
Q 4.3   I feel that psychological aspects regarding HIV/AIDS need to  
            be emphasized. 
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The vast majority of respondents (98 per cent) indicated that they felt that 
psychological aspects regarding HIV/AIDS, need to be emphasized. 
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Q 5.1   I am confident that peer educators are well trained and  
            equipped to deal with HIV/AIDS issues. 
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The proportion of respondents that indicated that they felt confident that 
peer educators are well trained and equipped to deal with HIV/AIDS 
issues, was 70 per cent.  It is significant that 24 per cent of respondents 
were uncertain and 6 per cent disagreed with the above statement. 
 
Q 5.2   I feel that the whole workforce should be involved in practical  
    community involvement, not just the peer educators. 
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The majority of respondents (82 per cent) indicated that they felt that the 
whole workforce should be involved in practical community involvement, 
not just the peer educators. 
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Q 5.3   I am satisfied that HIV/AIDS information is distributed in my  
            home language. 
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The vast majority of respondents (92 per cent) were satisfied that 
HIV/AIDS information is distributed in their home language. 
 
Q 6.1   I am concerned that HIV/AIDS employees face discrimination  
            in the workplace. 
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Employees varied in their response to this question from strongly agree to 
strongly disagree.  It is significant that 40 per cent of respondents were 
concerned that HIV/AIDS employees face discrimination in the workplace.   
Twenty four per cent of respondents were unsure of the above statement 
and 36 per cent of respondents believed that HIV/AIDS employees do not 
face discrimination in the workplace. 
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Q 6.2   I feel that the stigma attached to HIV/AIDS is perpetuated          
            through ignorance and can be addressed. 
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The vast majority of respondents (94 per cent) indicated that they felt that 
the stigma attached to HIV/AIDS is perpetuated through ignorance and 
can be addressed. 
 
Q 6.3   I believe DCSA HIV/AIDS Workplace Project has reduced the      
    stigma attached to HIV/AIDS. 
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The proportion of respondents who indicated that they believe the DCSA 
HIV/AIDS Workplace Project has reduced the stigma attached to 
HIV/AIDS, was 66 per cent.  It is significant that 30 per cent of 
respondents were uncertain about the above statement and 4 per cent 
strongly disagreed. 
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Q 7.   I am aware of the following impacts of HIV/AIDS in my 
          department: 
• Loss of productivity 
• Rise in cost 
• Absenteeism 
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Employees varied in their response to the question of whether they were 
aware of the impacts of HIV/AIDS in their department.  The proportion of 
respondents that agreed with the above statement was 76 per cent.  It is 
significant that 24 per cent of respondents were uncertain or disagreed.  
 
Q 8.   I am satisfied that DCSA is addressing the impact of HIV/AIDS       
          effectively through: 
• Education, Awareness and Advocacy 
• Integrated Health Care 
• Community Involvement 
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The majority of respondents (88 per cent) indicated that they were 
satisfied that DCSA is addressing the impact of HIV/AIDS effectively 
through the various components of the Workplace Project. 
 
 
Summary:  Section B Part 2 
Generally, the response to most questions in this section had been either 
“agree” or “strongly agree” i.e. a positive response.  However, a few 
questions had a fair proportion of “uncertain”, “disagree” or “strongly 
disagree” responses.  All those questions that had a 20 per cent or higher 
response in the “uncertain”, “disagree” or “strongly disagree” category will 
be analysed in more depth.  Therefore, questions  2.1; 3.1; 3.2; 4.1; 5.1; 
6.1; 6.3; and 7 will be statistically analysed (refer to Annexure 4). 
 
See Annexure 4 for Statistical Analysis. 
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5.5 RESPONDENTS’ COMMENTS – QUALITATIVE QUESTIONS 
 
The following are the responses from employees regarding the qualitative 
questions in the questionnaire.  Respondents’ views regarding different 
aspects of the DCSA HIV/AIDS Workplace Project are given in this 
section.   
 
All significant responses to the qualitative questions have been quoted 
below under the relevant heading. 
 
5.5.1   Occupational Health Services  
 
“The staff at occupational health services must get a private room for 
counselling people.” 
 
“There must be a private room for counselling people at occupational 
health services”. 
 
“DCSA should improve their way of counselling – they must not counsel 
you between those curtains when other patients are still getting some help 
on the other side.  By doing so the person on the other side will hear what 
is said on the other side.  That I know is happening and we talk about 
those people on line”. 
 
“When you have been tested, it must be a secret between you and the 
counsellor”. 
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5.5.2   Antiretroviral Treatment (ART)   
 
“I need more info about ART”. 
 
“We need a thorough understanding of these drugs (ART) and the 
dangers and when to start the treatment.  Also how and which vitamins to 
take”. 
 
“ART must be given to all employees because those booster are too 
expensive”. 
 
“Some treatment are not understandable, that is why we must use our own 
language”. 
 
5.5.3   Peer Educators    
 
 “If management can only give us time to talk to our fellows – like maybe 
10 min once a week for the peer educators please”. 
 
“DCSA must train more peer educators and give them time to address the 
employees”. 
 
“If management in our plant can be understanding about this crisis and 
give TIME for peer educators just once a week an half hour”. 
 
“Company need to give peer educators more time to teach us more about 
HIV/AIDS”. 
 
“Peer educators should be tested so that they can practice what they 
preach”.  
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“I think the company also needs to train team managers as peer educators 
because sometimes they make life difficult for those affected by AIDS”. 
 
5.5.4   Stigma  
 
“With the help of peer educators the stigma and discrimination is being 
phased out”. 
 
“DCSA must do more to eliminate stigma of HIV/AIDS”. 
 
“You will be able to remove stigma once you have proper participation of 
workers affected/infected by HIV/AIDS.  By telling their fellow workers 
about the matter at hand and how it has changed lives”. 
 
5.5.5   Community Involvement    
 
“DCSA peer educators should be used after hours in the community to 
spread knowledge on the subject”. 
 
“DCSA must be seen in our communities by calling meeting with leaders to 
address HIV/AIDS”. 
 
“DCSA must take its projects to our communities and also provide basic 
living needs to affected people”. 
 
 
5.5.6 Suggestions   
(Regarding the question:  “What more do you think DCSA can do to 
help prevent the spread of HIV/AIDS and support people affected 
by the Virus?”) 
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“Discuss HIV/AIDS issues at the hourly employed workers’ weekly team 
meetings on a regular basis”. 
 
“I feel that employees should be made more aware of HIV/AIDS by being 
able to see what the virus can do to a person.  The saying goes – seeing 
is believing”. 
  
“Play cassettes during lunch times that show how HIV/AIDS is dangerous”.   
 
“I think we need to form circles of support for those workers that are 
affected by HIV/AIDS”. 
 
 
Summary:  Qualitative questions 
Generally, the response to the qualitative questions listed above, 
correspond with the response to questions, identified as significant, in 
Section B Part 2.  The qualitative questions address the same issues.  
This will be dealt with in more detail in Chapter 6, during the discussion 
and interpretation of the findings of the empirical survey. 
 
 
5.6 CONCLUSION 
 
This concludes Chapter 5, which documented the results of the empirical 
study.  The results of a survey of 50 employees at DCSA were described.  
For a statistical analysis of significant results refer to Annexure 4.   
 
Chapter 6 will comprise of an integration of the findings from the literature 
survey and the results of the empirical survey.  The chapter will elaborate 
on the findings of the survey. 
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CHAPTER 6 
 
INTEGRATION OF THE FINDINGS FROM THE LITERATURE SURVEY 
AND THE FINDINGS OF THE EMPIRICAL SURVEY 
 
 
6.1   INTRODUCTION 
 
The previous chapter focused on the results of the empirical survey.  The 
findings of the empirical survey will be discussed in this chapter. 
 
In chapter six the findings of the literature survey and the empirical survey 
will be integrated. 
 
Firstly, the findings of the Literature survey “Addressing HIV/AIDS at 
DaimlerChrysler South Africa” will be presented.  This comprises the final 
evaluation of the DCSA HIV/AIDS Workplace project 2001 – 2003. 
 
Thereafter, the findings and interpretation of the empirical survey (results 
and statistical analysis) will be documented. 
 
 
6.2     FINDINGS OF LITERATURE SURVEY 
 
6.2.1 Final Evaluation of the DCSA HIV/AIDS Workplace Project  
(2001 – 2003) 
 
DaimlerChrysler South Africa’s HIV/AIDS Workplace Project was 
established and conducted in partnership with GTZ over a period of 3 
years (2001 – 2003).  In accordance with GTZ project procedures, final 
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evaluation of project outcomes was conducted by an independent panel of 
experts.  The panel comprised members capable of assessing the project 
technically and operationally, and was chaired by Dr Bernard Fourie of the 
South African Medical Research Council 
(www.hivaids.daimlerchrysler.co.za:  2004). 
 
According to the Final Evaluation of the DaimlerChrysler SA HIV/AIDS 
Workplace Project 2001 – 2003, the project was successful in ensuring 
(www.hivaids.daimlerchrysler.co.za: 2004): 
• A sound workplace programme management system; 
• Services for voluntary HIV/AIDS counselling and testing with good 
uptake; 
• Improved HIV/AIDS, sexually transmitted infection and tuberculosis 
treatment services; 
• Human resources and employee benefit management processes 
designed to meet the impact of an increasing HIV prevalence; 
• A solid information, education, communication and advocacy 
framework; and 
• A platform for meaningful community involvement. 
 
6.2.2 Key Outcomes 
 
Key outcomes of the Project included (www.hivaids.daimlerchrysler.co.za: 
2004): 
 
• 75 per cent of employees had an HIV test to determine their HIV 
status, with 40 per cent using the DCSA on-site HIV Voluntary 
Counselling and Testing (VCT) services. 
• The survival rate of DCSA employees and family members on anti-
retroviral treatment is a 48-month survival rate of more than 90 per 
cent. 
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• No children of DCSA mothers, utilising the prevention of mother to 
child transmission treatment services offered by the DCSA medical 
aid scheme, were infected with HIV. 
• During the project period the tuberculosis cure rate improved from 
40 per cent to 100 per cent amongst patients using the services of 
on-site DOTS (Directly Observed Treatment – Short Course). 
• The incidence of sexually transmitted infections (STI’s) decreased 
by 50 per cent amongst employees utilising the on-site 
Occupational Health Services. 
•  A 56 per cent reduction in HIV/AIDS mortality (deaths from AIDS) 
was achieved during the project period. 
 
This indicates that the project was successful and other employers should 
seriously consider implementing such a project. 
  
6.2.3 DCSA HIV/AIDS Project Awards   
 
The DCSA HIV/AIDS project has received significant public attention.  The 
Global Health Initiative, the South African Business Coalition on HIV/AIDS, 
the Global Business Coalition on HIV/AIDS, and the Global Compact 
Learning Forum have selected it for “best practice” analyses 
(www.weforum.org: 2004).  In recognition of its commitment to addressing 
the AIDS epidemic in South Africa, DaimlerChrysler has received, 
amongst others, the Award for Business Excellence in the Workplace 
2002 from the Global Business Council on HIV/AIDS.  The attention DCSA 
received from these organizations indicates that the company has 
communicated successfully its engagement to more systematically and 
strategically address the HIV/AIDS issue.  DCSA has thereby also 
enhanced the corporation’s image among various constituencies, 
domestically and internationally (www.weforum.org: 2004).  
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6.3 FINDINGS OF EMPIRICAL STUDY 
 
The empirical survey intended to gather information on the attitude and 
perception of DCSA employees regarding HIV/AIDS at the workplace. 
The specific objectives of the survey were to identify: 
• How effectively is DCSA addressing the HIV/AIDS pandemic; 
• Employees’ attitude and perception regarding the impact of 
HIV/AIDS at the workplace; and 
• The attitude and perception employees have regarding different 
aspects of the DCSA Workplace Project. 
 
The results of the empirical survey were presented in the following 
sequence: 
• Biographical information; 
• Respondents’ understanding of HIV/AIDS; and  
• Respondents’ opinion. 
 
6.3.1 Biographical Information 
 
From the data it is evident that the sample comprised employees who are 
well-educated, predominantly male, with mostly 2 – 10 years service and 
with the highest frequency of employees in the 31 – 40 year age group.  
 
6.3.2 Respondents’ Understanding of HIV/AIDS 
 
The respondents demonstrated a high level of knowledge regarding 
HIV/AIDS.  While the group as a whole was well-informed about all aspect 
of HIV and AIDS, important issues raised were: 
• The high number of respondents (28 per cent) that believe HIV can 
be cured if diagnosed early and treated. 
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• The high number of respondents (24 per cent) that believe that HIV 
is only spread through sexual intercourse with an infected person. 
 
These issues need to be addressed in an educational campaign. 
It seems that the people most in need of HIV/AIDS education and 
information are to be found in the ranks of the hourly paid workers. 
 
In the statistical analysis (refer to Annexure 4), Two-way frequency tables 
showed how Employment level, Age and Gender differed in terms of their 
response to the above two questions.  It is significant that in the 41 – 50 
year age group, 50 per cent of the respondents gave the wrong answer to 
the above two questions. 
 
6.3.3   Respondents’ Opinion 
 
The results from the empirical study show that employees perceive the 
DCSA HIV/AIDS Workplace Programme as an excellent programme.  
They indicated that this project had enlightened them and that they believe 
that DCSA is promoting HIV/AIDS awareness in a positive manner.  
 
It was evident from the results that employees are aware of the impact of 
HIV/AIDS at their workplace and realised the need for comprehensive 
intervention.  
 
Generally, respondents were satisfied with all aspects of the HIV/AIDS 
Workplace programme. 
 
In the statistical analysis (refer to Annexure 4), the table showing the 
average response for all questions in Part 2 – Your Opinion, indicated that 
the mean varied from 1.3 to 2.9. i.e. strongly agree to agree.  It can be 
interpreted that the respondents on average tended to agree with the 
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positive statements in the questionnaire regarding the DCSA HIV/AIDS 
Workplace Programme. 
 
However, certain questions, as identified in the previous chapter and that 
had subsequently been statistically analysed, more than 20 per cent of 
respondents had a negative perception. 
 
These questions deal with Occupational Health Services (OHS), 
Antiretroviral Treatment (ART), Peer educators, Discrimination, Stigma 
and the Impact of HIV/AIDS in the employees’ department. 
 
When these questions were statistically analysed in terms of employment 
level, gender and age it was found that (refer to Annexure 4): 
 
i) Male and female employees differed significantly in their response 
to whether they were confident that staff at OHS maintain 
confidentiality regarding employees’ HIV status.  Male employees 
were more agreeable to this statement than females. 
 
ii) Hourly paid and administrative employees differed significantly in 
their response to whether they understood what ART entails.  
Hourly paid employees had a higher positive response than 
administrative employees. 
 
iii) Male and female employees differed significantly in their response 
to whether they were aware of the HIV/AIDS support and treatment 
offered to HIV/AIDS employees and their families.  Male 
respondents were more aware of this than female respondents. 
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The employees’ response to the qualitative questions in the questionnaire 
correlate with the aspects mentioned above, as they address the same 
issues. 
 
In essence, the results from the Empirical survey indicate that the 
following  aspects need consideration: 
 
• Occupational Health Services (OHS) 
• Antiretroviral Treatment (ART)  
• Peer Educators 
• Stigma 
 
From the results of the qualitative questions it was evident that employees 
felt strongly about DCSA’s role in community involvement as employees  
had various meaningful suggestions.   
 
(i) Occupational Health Services 
 
Occupational Health Services (OHS) at DCSA play a key role in planning 
for and dealing with the impact of HIV/AIDS on employee performance 
and productivity.     
 
Confidentiality, especially in terms of HIV status, is a controversial  issue.  
A fair proportion of respondents expressed concern over lack of trust in 
the confidentiality of the Occupational Health Services. 
 
Employees requested that a private room be available for counselling. 
It seems counselling is presently being conducted behind curtains - 
audible to other employees.  This needs to be rectified, because 
employees need to be reassured of the integrity of the system as regards 
maintenance of confidentiality. 
  83
 
(ii) Antiretroviral Treatment 
    
The provision of Antiretroviral Treatment has been implemented at DCSA 
and is accessible.   
 
However, there is a need for a better understanding by the workforce of: 
• what Antiretroviral Treatment entails; 
• the benefits and risks associated with ART; and 
• the benefits of joining AfA (Aid for AIDS). 
 
 
(iii) Peer Educators 
 
The peer educators play a crucial role in the success of the DCSA 
HIV/AIDS Workplace project. 
 
There seem to be a definite need from Peer educators to have time 
allocated to them to address fellow workers in the weekly meetings. 
Employees also expressed a desire to learn more about HIV/AIDS from 
the peer educators. 
 
HIV/AIDS must be taking an emotional toll on peer educators, counsellors, 
and occupational health practitioners.  Yet, there appears to be no 
available literature on the provision and type of support, if any, offered to 
them.   
 
The following questions need to be addressed: 
• How are peer educators motivated and sustained?  
• What are the peer educators’ level of acceptance in the  
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organisation, especially by more senior levels of employees?  
• What resources are they provided with? 
 
 
(iv) Stigma      
 
Concerns about HIV/AIDS-related  stigma is not new.  It is widely 
recognized that there are three phases to the AIDS epidemic in any 
society (www.unaids.org: 2004).  The first of these is the epidemic of HIV 
infection.  This enters a community silently and unnoticed.  Next follows 
the epidemic of AIDS, which appears when HIV triggers life-threatening 
infections. Finally, there is the third epidemic – the epidemic of stigma, 
discrimination, blame and collective denial – that makes it so difficult to 
effectively tackle the first two (www.unaids.org: 2004).  HIV/AIDS-related 
stigmatization and discrimination make prevention and treatment difficult 
by forcing the epidemic out of sight and underground. 
 
DCSA need clear thinking about what stigma and discrimination are, 
where they come from, particularly the social and cultural drivers that 
sustain them. 
 
The company need to focus on a better understanding of how stigma and 
discrimination fuel the epidemic, and the role that greater access to 
treatment could have in reducing prejudice against people living with 
HIV/AIDS. 
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6.4 CONCLUSION 
 
From the findings of the literature survey is it clear that the DCSA 
HIV/AIDS Workplace project has been successful. 
 
DCSA employees who completed the questionnaire were generally 
satisfied with all aspects of the DCSA Workplace programme.  A few 
aspects, as detailed above, need attention. 
 
Therefore, it can be said that the findings of the literature survey 
correspond with the findings of the empirical survey. 
 
The next chapter is the final chapter of this research project and will 
document the conclusion and recommendations of the research project. 
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CHAPTER 7 
 
CONCLUSION AND RECOMMENDATIONS 
 
 
7.1     INTRODUCTION 
  
The previous chapters documented the problem, the research design, the 
findings and interpretation of the empirical study.  In this chapter key 
conclusions that can be drawn from these previous chapters are 
summarised.  In addition a comprehensive list of recommendations is 
given. 
 
 
7.2     MAIN PROBLEM 
 
The Main problem addressed by this research has been: 
“How effective is DCSA in addressing the HIV/AIDS pandemic? 
 
The Sub-problems have been the following: 
(a) What have previous studies shown is the impact of HIV/AIDS at the  
 workplace? 
(b) What does empirical research reveal regarding the current situation 
 at DCSA to address the impact of HIV/AIDS? 
(c) What strategic insights can be drawn from a comparison of the   
 literature study and empirical research? 
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7.3      CONCLUSION 
 
DCSA is attempting to limit the impact and consequences of the HIV/AIDS 
pandemic on its workers, their families, and surrounding communities 
through its HIV/AIDS workplace programme. 
 
As reported in chapter two, over the next decade the number of 
employees lost to AIDS in South Africa could be the equivalent of 40 to 50 
per cent of the current workforce in some companies.  The cost of 
HIV/AIDS for most businesses will be substantial.  South Africa lost $72bn 
between 1992 and 2002 mainly due to deaths, absenteeism and lower 
productivity. 
 
Therefore, investment in HIV/AIDS programmes has been proposed as 
good business practice, as costs of prevention programmes are recovered 
by savings in terms of costs to the company of the pandemic. 
 
DCSA established its workplace and community HIV/AIDS project to 
address the increasing financial burden associated with HIV/AIDS. 
The company can achieve a positive economic effect by providing 
treatment and care that keep HIV positive employees in the workforce 
longer, thereby delaying costs further into the future.  By extending the 
average period from HIV infection to death from AIDS from nine to ten 
years, for example, would reduce the total cost to DCSA by 10 per cent. 
 
A comparison of the literature study and the empirical research show that 
the findings of the literature survey correspond with the findings of the 
empirical survey. 
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From the literature review it is evident that the DCSA Workplace Project 
has been successful in limiting the impact and consequences of the   
HIV/AIDS pandemic.  According to the Final Evaluation of the DCSA 
HIV/AIDS Workplace project, key outcomes included a 56 per cent 
reduction in HIV/AIDS mortality. 
  
The HIV/AIDS Project achieved its objectives and received numerous 
awards for excellence, including Global Compact Learning Forum 
selection for “best practice” analyses and the Award for Business 
Excellence in the Workplace from the Global Business Council on 
HIV/AIDS.   
 
The objectives of the empirical research have been achieved as the 
following findings were identified from the survey and statistical analysis: 
 
• The majority of DCSA employees who completed the questionnaire 
felt that DCSA is effectively addressing the HIV/AIDS pandemic; 
• Employees were generally satisfied with all aspects of the DCSA 
Workplace Programme although a fair proportion felt that there was 
room for improvement; and 
• The employees’ attitude and perception of the DCSA HIV/AIDS 
Workplace Programme as reflected in the survey, showed that they 
considered the programme to be effective.   
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Overall the DCSA Workplace programme is an excellent programme with 
a lot of commitment from management, health services and peer 
educators.  However, DaimlerChrysler South Africa need to:  
 
• Ensure sustainability of the programme; 
• Address issues of stigma and discrimination; 
• Address negative perceptions regarding breaches of  
confidentiality at OHS; 
• Supply employees with more information regarding ART; and 
• Support peer educators.  
 
The survey confirms that whereas education remains the most important 
response to the HIV/AIDS pandemic, the challenge for DCSA is translating 
knowledge and information into appropriate behaviour. 
 
It can be concluded that DaimlerChrysler South Africa is effective in 
addressing the HIV/AIDS pandemic.  With a few improvements, as 
recommended below, the results of the DCSA HIV/AIDS Workplace 
programme can be even more impressive. 
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7.4 RECOMMENDATIONS     
 
Based on the findings if this survey, the following recommendations are 
made: 
 
• DCSA should strengthen the knowledge employees already have 
about HIV/AIDS. 
 
• An educational campaign should be put in place to encourage 
employees to acknowledge HIV/AIDS, to change their behaviour 
and to increase the use of DCSA’s health services. 
 
• DCSA should communicate its processes for guaranteeing the 
confidentiality of employees’ HIV status. 
 
• The issue of confidentiality is vital in gaining the confidence of 
employees.  A private room for counselling is thus a necessity. 
 
• The workforce need to be supplied with more information regarding 
what Antiretroviral Treatment entails, the benefits and risks 
associated with ART and the benefits of joining AfA. 
 
• Peer educators should be given more time to address their fellow 
workers on issues of HIV and AIDS.  They need the support of the 
company and should be provided with the necessary resources to 
be effective in their task. 
 
• DCSA need to ensure empathy and a caring environment for 
people living with AIDS. 
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• The negative attitudes towards the stigmatising and the 
discriminatory perceptions of people with HIV/AIDS should be 
addressed as part of the education campaign.   
 
• DCSA need to reduce levels of stigma through: 
-  The dissemination of information; 
-  Counselling approaches; and 
-  Creating a supportive legal environment to enable employees        
            to challenge discrimination. 
 
 
The researcher is confident that if the above recommendations are 
adhered to, this action will lead to the continuous improvement of the 
DCSA Workplace Programme, and thus contribute to the lowering of 
HIV/AIDS prevalence rates at DaimlerChrysler South Africa. 
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DaimlerChrysler Group of Companies in South Africa 
 
HIV/AIDS Workplace Policy  
DaimlerChrysler South Africa Pty Ltd 
DaimlerChrysler Services Pty Ltd 
debis Fleet Management Pty Ltd  
April 2004  
1. Purpose, Preamble and General Principles:  
1.1. The Purpose of this HIV/AIDS Workplace Policy is to ensure a uniform and 
fair approach to the effective prevention of HIV/AIDS amongst employees and 
their families and access to comprehensive care, support and treatment for 
employees and their dependants living with HIV/AIDS. 
1.2. The Management and the representative HIV/AIDS Task Force of 
DaimlerChrysler South Africa Pty Ltd and South African operations of 
DaimlerChrysler Services and debis Fleet Management, hereafter collectively 
called DCSA, acknowledge the seriousness of the HIV/AIDS epidemic in South 
Africa. DCSA understands the significant impact of HIV/AIDS on all institutions 
of society - including the workplace. DCSA regards AIDS as a chronic, life 
threatening disease with significant political, social, economic and human rights 
implications. DCSA, moreover, seeks to minimise these implications through 
comprehensive, proactive and needs-based HIV/AIDS workplace strategies; and 
commits itself to providing leadership in implementing such strategies. 
1.3. General Principles: 
1.3.1. Consultation: The DCSA HIV/AIDS workplace policy has been developed 
and will be implemented in consultation with DCSA employees at all levels  
1.3.2. Equity: Employees living with HIV/AIDS have the same rights and 
obligations as all staff members and they will be protected against all forms of 
unfair discrimination based on their HIV status  
1.3.3. Confidentiality: All information and test results of an employee concerning 
HIV and AIDS are confidential. An employee may give informed consent to 
release such information to individuals specifically identified.  
1.3.4. Rights and Responsibilities: This policy is in compliance with existing 
South African laws and guidelines regarding HIV/AIDS [1], as well as with the 
Southern African Development Community (SADC) Code on HIV/AIDS and 
Employment [2].  
1.3.5. Breaches of this policy will be dealt with under the normal disciplinary and 
grievance procedures of DCSA.  
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2. Basic Information on HIV/AIDS: 
2.1. What is HIV & AIDS? 
AIDS is a disease that affects millions of South Africans. It is caused by a virus 
called HIV (Human Immune Deficiency Virus). This virus slowly weakens a 
person’s ability to fight off other diseases, by damaging and destroying 
important cells that control and supports the human immune system. After a 
person is infected with HIV, he or she, although infectious to others, can look 
and feel fine for many years before AIDS develops.  
2.2. HIV causes AIDS 
HIV causes AIDS. The average period between infection with HIV and 
development of AIDS is 7 years in the absence of appropriate care, support and 
treatment. AIDS is an abbreviation for Acquired Immune Deficiency Syndrome, 
which is a term to describe a set of opportunistic infections and cancers, which 
would not be life-threatening, if HIV had not already significantly damaged or 
destroyed the body’s immune system. 
2.3. Transmission and factors fuelling the epidemic  
2.3.1. There is very little chance of HIV being transmitted in the workplace. In 
order for a person to be infected, the virus must gain entrance into a person's 
blood stream. There are a limited number of modes of transmission. The modes 
of transmission in order of importance are: 
Unprotected sex with an HIV infected person 
From an infected mother to her child (during pregnancy, at birth or through 
breast feeding) 
Intravenous drug use with contaminated needles 
Transfusion with infected blood and blood products 
Unsafe, unprotected contact with infected blood and the bleeding wounds of an 
infected person  
2.3.2. A range of societal circumstances increase the risk of HIV transmission, 
shorten the time to development of AIDS, and worsen the prognosis in 
HIV/AIDS. These factors continue to fuel the epidemic in spite of behaviour 
modification attempts and other public health interventions and include: 
Poverty 
Limited access to health and social services 
Poor nutrition 
Migrant labour 
Rapid urbanisation 
Unemployment 
Inadequate education 
Stigmatisation and discrimination 
The inferior position of women in society 
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2.4. Prevention, Care, Support and Treatment 
Preventing new infections remains the cornerstone of a sustainable HIV/AIDS 
strategy. There is still no cure or vaccine for HIV/AIDS. There have been many 
major advances in comprehensive care, support and treatment. Anti-retroviral 
drug combinations are available, which, when properly used result in 
significantly prolonged survival of people living with HIV/AIDS. Holistic care, 
support and treatment of people living with HIV/AIDS including appropriate 
psycho-social support, nutritional support, prevention and treatment of 
opportunistic diseases and anti-retroviral treatment dramatically improves length 
and quality of life for people living with HIV/AIDS. 
2.5. HIV/AIDS is a Development Problem 
HIV/AIDS is a key obstacle to sustainable development. Business has a critical 
role in progressively and systematically addressing HIV/AIDS as a 
developmental problem, in partnership with other institutions in society, to 
ensure sustained economic growth and development. Business must address 
the development of and support for appropriate and sustainable prevention, 
care, support and treatment strategies. 
3. Creating a Non-discriminatory and Caring Environment  
3.1. Eliminating Stigmatisation & Discrimination  
Through the provision of information, education and communication about HIV 
and AIDS and implementation of normal DCSA industrial relations procedures, 
this policy aims to protect all employees living with HIV/AIDS from stigmatisation 
and discrimination. It guarantees that job access, -status, -promotion, -security, 
training and development will not be influenced by the HIV status of an 
employee. 
3.2. Voluntary Counselling & Testing 
DCSA rejects HIV testing as a prerequisite for recruitment, access to training 
and development, or for promotion. DCSA promotes and facilitates access to 
appropriate Voluntary Counselling and Testing (VCT) for all employees and 
family members. DCSA ensures provision of VCT services at its occupational 
health services or ensures referral to appropriate community-based services. 
3.3. Confidentiality & Disclosure 
DCSA guarantees confidentiality of any medical information relating to HIV 
status that any of its representatives may have in their possession by virtue of 
their position in the company. DCSA strives to create a climate that allows for 
and encourages voluntary disclosure of an individual’s HIV status. DCSA also 
guarantees that an employee will not be unfairly discriminated against based on 
their disclosed HIV status.  
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3.4. Performance Management 
With this policy, DCSA acknowledges the desire and the ability of employees 
living with HIV/AIDS to work. It therefore, guarantees that employees living with 
HIV/AIDS may continue to work as long as they are able to perform their duties 
in accordance with job requirements. When due to medical reasons an 
employee may no longer be able to continue with his or her normal employment 
duties, DCSA will make efforts to reasonably accommodate an employee in a 
modified job or other position in line with existing legislation and company 
policies. Normal DCSA incapacity management, disability management and 
disability claim procedures will be utilised. 
4. DCSA HIV/AIDS Workplace Programme  
4.1. Prevention, Care, Support and Treatment 
The DCSA HIV/AIDS Workplace Programme ensures promotion of and access 
to prevention, care, support and treatment services, including: 
4.1.1. Promotion of proper condom use and access to condoms 
4.1.2. Treatment of Sexually Transmitted Infections (Syndromic Management) 
4.1.3. Appropriate treatment for people with Tuberculosis in line with the Ministry 
of Health's National TB Control Policy (DOTS) 
4.1.4. Occupational Health and Employee Wellness Services 
4.1.5. Provision of or referral to HIV VCT Services (including ongoing psycho-
social care and support) 
4.1.6. Comprehensive Health Care for people living with HIV/AIDS funded within 
the framework of the company medical aid scheme. This includes wellness 
promotion, appropriate anti-retroviral drug treatment according to Southern 
African HIV Clinicians Society protocols, and appropriate prevention and 
treatment of opportunistic diseases. 
4.1.7. Managing the risk of HIV infection at the workplace, following injury at 
work involving exposure to blood, and potential exposure to bloodborne 
pathogens, including HIV, using standard procedures and universal precautions. 
Relevant HIV/AIDS information is included into Occupational Health training and 
First Aid training. Emergency care and treatment for DCSA medical personnel 
and people performing First Aid following potential occupational HIV exposure is 
provided using standard protocols. 
4.1.8. Employees living with HIV/AIDS, who are already registered with the 
company’s medical aid scheme HIV/AIDS disease management programme, 
who are retrenched will have ongoing access to anti-retroviral treatment, and the 
requisite laboratory monitoring, for up to two years from date of retrenchment. 
4.1.8.1. This will also apply to dependants registered with the medical aid 
scheme and with the HIV/AIDS disease management programme at the time of 
retrenchment. This service will be directly funded by DCSA. The HIV/AIDS 
Programme Coordinator will designate service providers that are accessible to 
the retrenched employee and his/her registered dependants. Access will be 
dependent on registration with the HIV/AIDS disease management programme 
before retrenchment and on compliance with medical advice, monitoring and 
treatment provided by the designated service providers. 
4.1.8.2. This post-employment treatment benefit is extended to compulsorily 
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retrenched employees (and their registered dependants) only. 
4.1.8.3. The benefit is not extended to employees who resign or to employees 
whose services are terminated as a result of a disciplinary process. 
4.1.8.4. Employees living with HIV/AIDS who leave employment on the grounds 
of disability may remain disability pensioner members of the medical aid scheme 
with full access to HIV/AIDS benefits. 
4.2. Information, Education and Communication (IEC) 
The DCSA HIV/AIDS Workplace Programme will facilitate continuous HIV/AIDS 
information, education and communication through ensuring the systematic and 
ongoing provision of credible information about HIV/AIDS using all company 
media and communication methods.  
Coordinated Peer Educator Services will be established and maintained.  
DCSA commits itself to regular and formal communication within the company 
about the HIV/AIDS Workplace Programme and its development. 
4.3. Risk Management 
The DCSA HIV/AIDS Workplace Programme will proactively manage the impact 
of HIV/AIDS on the company, its employees and family members. DCSA will 
conduct periodic formal HIV/AIDS Risk Assessments of the organisation and its 
employees. This will include HIV prevalence and impact studies without 
compromising confidentiality of HIV status of any individuals, in consultation and 
with the consent of employees and employee organisations. Further, DCSA will 
continuously review and adapt its risk management strategies and employee 
benefits to mange current and future HIV/AIDS impacts. These employee 
benefits include insured death and disability benefits, funeral cover, and the 
company medical aid scheme.  
4.4. Community Involvement and Partnerships 
DCSA considers community involvement and partnerships with other 
stakeholders and institutions an integral part of its HIV/AIDS strategy. It 
therefore, supports community-based initiatives in its employee’s communities. 
DCSA is committed to create and foster partnerships with governmental and 
non-governmental organisations for the implementation of its HIV/AIDS 
Programme. 
4.5. Monitoring and Evaluation 
DCSA will conduct regular workplace HIV Prevalence Surveys, HIV/AIDS Risk 
Assessments and Knowledge, Attitudes, Practice/Behaviour (KAP/B) 
Assessments. An appropriate, comprehensive monitoring, evaluation and 
reporting system for the HIV/AIDS Workplace Programme will be designed 
implemented and maintained. 
 
5. Implementation and Coordination Responsibilities  
ANNEXURE 1 
 - 6 - 
5.1. To coordinate and implement the HIV/AIDS Workplace Policy and 
Programme, DCSA will designate national and local co-ordinators with clearly 
defined roles, responsibilities and performance management targets. 
5.2. As the major consultative and communication structure a HIV/AIDS Task 
Force will be established and maintained. The Task Force consists of 
employees representing all constituents of the company, drawn from the 
representative Trade Union, Staff Committee, Medical Services, Production 
Management, Human Resources Management, and representatives of the GTZ.
5.3. The HIV/AIDS Task Force will review this policy at regular intervals and 
conduct a formal review in the 1st Quarter of each year. 
Footnotes: 
[1] 
Constitution of the Republic of South Africa act No. 108 of 1996.  
Employment Equity Act, 55 of 1998  
Occupational Health and Safety Act, 85 of 1993  
Mines Health and Safety Act No. 29 of 1996  
Compensation for Occupational Injuries an Diseases Act No. 130 of 1993  
Basic Conditions of Employment Act, 75 of 1997  
Labour Relation Act No. 66 of 1995 (arbitrary dismissal, ability to work of HIV+ 
staff)  
The Medical Schemes Act, No 131 of 1998  
The South African Commission for Employment Equity Code of Good Practice 
on key aspects of HIV/AIDS and Employment, 2000  
Technical assistance Guidelines on HIV/AIDS and Employment. Department of 
Labour (South Africa), May 2003 
[2]  
Adopted in 1997 by the SADC Council.  
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RESEARCH  PAPER
DaimlerChrysler South Africa is attempting to limit the 
impact and consequences of the HIV/AIDS epidemic on its 
workers, their families and surrounding communities through 
its HIV/AIDS Workplace Project.
Research Topic:
“A study to determine the degree to which the 
HIV/AIDS pandemic is being addressed at 
DaimlerChrysler South Africa.”
The final report from this Research Paper can be useful to 
the continuous improvement of the DCX-SA HIV/AIDS 
Workplace Project.
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RESEARCH  METHODOLOGY
1. Literature survey
2. Empirical study
• Measuring instrument
Questionnaire
• Sample
Random sample 50 employees
30 - Hourly paid
10 - Management
10 - Admin/health workers
• Statistical analysis of data
Statistician will provide assistance with analysis of data
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QUESTIONNAIRE
DCX-SA (East London) HIV/AIDS QUESTIONNAIRE  July 2004
Section A Biographical information
Section B Part 1- Your understanding of HIV/AIDS
Part 2- Your opinion
Advantages
" Awareness amongst EL employees of the DCX-SA HIV/AIDS 
Workplace Programme.
" Employees can respond to questions with assurance that their responses 
will be anonymous, and so they may be more truthful than they would be 
in a personal interview, particularly when they are talking about 
controversial issues.
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OBJECTIVE OF SURVEY
" To identify the perception and attitude employees 
have towards the DCX-SA HIV/AIDS Workplace 
Project.
" The difference among employees of different job 
bands, age, race, gender and qualification with regard 
to the above information.
" Employees’ understanding of HIV/AIDS constitutes 
another variable to compare with their perceptions 
and attitudes regarding the DCX-SA HIV/AIDS 
Workplace Project.
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This is an anonymous study.  Do not provide your name. 
 
Participation in the study is completely voluntary. 
 
No attempt will be made to identify those who filled in this questionnaire. 
 
It will take no longer than 10 minutes to complete the entire questionnaire. 
 
 
 
SECTION A  - BIOGRAPHICAL INFORMATION 
 
Please complete the following section.  
 
Completing this section is voluntary. 
 
Place an “X” in the appropriate block. 
 
 
1. Age  
  
Under 20  
21 – 30  
31 – 40  
41 – 50  
51 – 60  
61 and older  
  
2. Gender  
  
Male  
Female  
  
3. Race  
  
Asian  
Black  
Coloured  
Indian  
White  
  
4. Highest qualification  
  
Primary school  
High school – non Matric  
High school – Matric  
Diploma/Degree  
Honours  
Masters  
Doctorate  
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5.  Years of service  
  
0 – 1 year  
2 – 5 years  
6 – 10 years  
11 – 15 years  
15 or more years  
  
6.  Employment level  
  
Hourly paid employee  
Management (both senior and middle management i.e. job band 1 – 5)  
Administrative, support services, health workers (job band 6 – 8)  
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SECTION B 
 
 
PART 1   “YOUR UNDERSTANDING OF HIV/AIDS” 
 
Please answer the following questions.   
 
Place an “X” in the appropriate bock. 
 
 
 YES NO NOT 
SURE 
1.  Can AIDS be cured?    
2.  Is there a difference between HIV and AIDS?    
3.  Do Sexually Transmitted Diseases (STD’s)  
     increase your chance of contracting HIV? 
   
4.  Can HIV be cured if diagnosed early and treated?    
5.  Can a person infected with HIV who is healthy still  
      transmit the virus to other people? 
   
6.  Is HIV spread only through sexual intercourse 
     (without condom) with an infected person? 
   
7.  Is it unsafe to work/live with a person who is HIV      
     positive or who has AIDS? 
   
8.  Can HIV positive people remain an active part of         
     society? 
   
9.   Do you think that anyone concerned about HIV    
      should undergo a HIV test? 
   
10.  Do you know where to go for help if you think you    
       might be HIV positive? 
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PART   2 “YOUR OPINION” 
 
 
Please answer the following questions according to how you currently feel or what you currently 
know about DCSA. 
 
Please answer all questions by placing an “X” in the appropriate block.   
 
If you have further comments or suggestions, add them in the category  
“other comments or suggestions”. 
 
 
 
QUESTION 1 
St
ro
ng
ly
 
ag
re
e 
Ag
re
e 
U
nc
er
ta
in
 
D
is
ag
re
e 
St
ro
ng
ly
 
D
is
ag
re
e 
1.1  I am aware of the DCSA Workplace Policy on 
HIV/AIDS. 
     
1.2  The DCSA HIV/AIDS Workplace Project has 
enlightened me. 
     
1.3  I believe DCSA is promoting HIV/AIDS 
awareness in a positive manner. 
     
Other comments or suggestions? 
 
 
 
     
      
      
QUESTION 2 
St
ro
ng
ly
  
ag
re
e 
Ag
re
e 
U
nc
er
ta
in
 
D
is
ag
re
e 
St
ro
ng
ly
 
D
is
ag
re
e 
   
   
   
   
  
2.1  I am confident that staff at Occupational Health 
Services (OHS) maintain confidentiality regarding 
employees’ HIV status. 
     
2.2  I am aware of the positive benefits of knowing my 
HIV status. 
     
2.3  I believe increasing Voluntary Counselling and 
Testing is a positive step forward in fighting the 
HIV/AIDS pandemic. 
     
Other comments or suggestions? 
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QUESTION 3 
St
ro
ng
ly
  
Ag
re
e 
Ag
re
e 
U
nc
er
ta
in
  
D
is
ag
re
e 
St
ro
ng
ly
  
D
is
ag
re
e 
3.1  I understand what Antiretroviral Treatment (ART) 
entails.  
     
3.2  I am aware of the benefits of ART and of joining 
AfA (Aid for AIDS). 
     
3.3  I feel that Antiretroviral Treatment should be 
available to all employees. 
     
Other comments or suggestions? 
 
 
 
     
      
QUESTION 4 
St
ro
ng
ly
 
Ag
re
e 
Ag
re
e 
U
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D
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e 
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ly
 
D
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4.1  I am aware of the HIV/AIDS support and 
treatment offered to HIV/AIDS workers and their 
families.                             
     
4.2  I support the extension of HIV/AIDS prevention to 
dependants of the workforce. 
     
4.3  I feel that psychological aspects regarding 
HIV/AIDS need to be emphasized. 
     
Other comments or suggestions? 
 
 
 
     
      
QUESTION 5 
St
ro
ng
ly
  
Ag
re
e 
Ag
re
e 
U
nc
er
ta
in
  
D
is
ag
re
e 
St
ro
ng
ly
  
D
is
ag
re
e 
5.1  I am confident that peer educators are well 
trained and equipped to deal with HIV/AIDS 
issues. 
     
5.2  I feel that the whole workforce should be involved 
in practical community involvement, not just the 
peer educators. 
     
5.3  I am satisfied that HIV/AIDS information is 
distributed in my home language. 
     
Other comments or suggestions? 
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QUESTION 6 
St
ro
ng
ly
  
Ag
re
e 
Ag
re
e 
U
nc
er
ta
in
  
D
is
ag
re
e 
St
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ng
ly
  
D
is
ag
re
e 
6.1  I am concerned that HIV/AIDS employees face 
discrimination in the workplace. 
     
6.2  I feel that the stigma attached to HIV/AIDS is 
perpetuated through ignorance and can be 
addressed. 
     
6.3  I believe DCSA HIV/AIDS Workplace Project has 
reduced the stigma attached to HIV/AIDS. 
     
Other comments or suggestions? 
 
 
 
     
      
QUESTION 7 
St
ro
ng
ly
  
Ag
re
e 
Ag
re
e 
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D
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e 
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ly
  
D
is
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e 
I am aware of the following impacts of HIV/AIDS in my 
department: 
     
7.1  Loss of productivity      
7.2  Rise in cost      
7.3  Absenteeism       
Other comments or suggestions? 
 
 
 
     
      
QUESTION 8 
St
ro
ng
ly
  
Ag
re
e 
Ag
re
e 
U
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in
  
D
is
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re
e 
St
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ng
ly
  
D
is
ag
re
e 
I am satisfied that DCSA is addressing the impact of 
HIV/AIDS effectively through: 
     
8.1  Education, Awareness and Advocacy      
8.2  Integrated Health Care      
8.3  Community Involvement      
Other comments or suggestions? 
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What more do you think DCSA can do to help prevent the spread of HIV/AIDS? 
________________________________________________________________ 
________________________________________________________________ 
________________________________________________________________ 
________________________________________________________________ 
 
 
What more do you think DCSA can do to support people affected by HIV/AIDS? 
_______________________________________________________________ 
_______________________________________________________________ 
_______________________________________________________________ 
_______________________________________________________________ 
 
 
THANK YOU for answering this questionnaire.   
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STATISTICAL ANALYSIS 
 
 
INTRODUCTION 
 
All significant responses to questions in the survey, as identified in  
Chapter 5, will be statistically analysed.   
 
This will be done in the following order: 
 
• Average response 
 
• Significant results to be analysed 
 
• Significant results analysed in terms of Employment level 
 
• Significant results analysed in terms of Gender 
 
• Significant results analysed in terms of Age 
 
• Respondents’ understanding of HIV/AIDS analysed 
 
• Frequency tables 
 
 
 
 
 
 
 
 
ANNEXURE 4 
  - 2 -  
 
AVERAGE RESPONSE  
 
Table showing the average response (on the 5 point scale) for all 
questions in Section B Part 2: 
 
Descriptive Statistics
Variable Valid N Mean Minimum Maximum Std.Dev.
P2_Q1_1
P2_Q1_2
P2_Q1_3
P2_Q2_1
P2_Q2_2
P2_Q2_3
P2_Q3_1
P2_Q3_2
P2_Q3_3
P2_Q4_1
P2_Q4_2
P2_Q4_3
P2_Q5_1
P2_Q5_2
P2_Q5_3
P2_Q6_1
P2_Q6_2
P2_Q6_3
P2_Q7_1
P2_Q7_2
P2_Q7_3
P2_Q8_1
P2_Q8_2
P2_Q8_3
50 1.500000 1.000000 3.000000 0.614452
50 1.620000 1.000000 4.000000 0.752953
50 1.440000 1.000000 3.000000 0.577115
50 2.060000 1.000000 5.000000 1.076843
50 1.380000 1.000000 3.000000 0.567486
50 1.380000 1.000000 3.000000 0.530306
50 1.980000 1.000000 4.000000 0.820403
50 1.980000 1.000000 4.000000 0.891914
50 1.580000 1.000000 4.000000 0.730949
50 2.000000 1.000000 4.000000 0.989743
50 1.520000 1.000000 3.000000 0.614120
50 1.400000 1.000000 3.000000 0.534522
50 2.180000 1.000000 5.000000 0.940907
50 1.720000 1.000000 3.000000 0.757008
50 1.720000 1.000000 5.000000 0.809132
50 2.900000 1.000000 5.000000 1.249490
50 1.540000 1.000000 3.000000 0.613122
50 2.100000 1.000000 5.000000 0.994885
50 2.060000 1.000000 5.000000 1.018402
50 2.020000 1.000000 5.000000 1.039819
50 1.860000 1.000000 5.000000 1.030356
50 1.580000 1.000000 3.000000 0.574634
50 1.660000 1.000000 3.000000 0.626295
50 1.840000 1.000000 3.000000 0.765586  
 
The first column, under “Variable”, gives the names that the researcher  
has given to the questions.  For example, P2_Q1_1 means it is Question 
1.1 in Part 2 of the questionnaire. 
 
The column “Valid N” shows how many cases (respondents) of the total 
sample size of 50 were used in the calculations.  This value is 50 for all 
variables since everybody gave an answer to each question.  
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The column “Mean” gives the average response on the 5-point scale 
where Strongly agree is given a code 1, Agree a code 2, up to Strongly 
disagree a code 5.  This means that if the average on a certain question is 
small (less than 3), the respondents (on average) tended to agree with the 
statement, while values greater than 3 indicate that the respondents (on 
average) tended to disagree.  The researcher used 3 as the cut-off-point, 
since it is exactly in the middle of the 5-point scale. 
 
The “Minimum” and “Maximum” columns give the minimum and maximum 
value that was observed for each question.  On all questions at least one 
Strongly agree (code 1) was recorded while there were many questions to 
which no one gave a Disagree or Strongly Disagree response (maximum 
smaller than 5).  
 
The “Std.Dev.” column gives the standard deviation for each question.  
This gives an idea of the spread of the values.  Big values indicate that the 
responses were more spread out around the mean value than small 
values.   
 
The above table indicates that the mean varied from 1.3 to 2.9 i.e. strongly 
agree to agree.  It can be interpreted that the respondents on average 
tended to agree with the positive statements in the questionnaire 
regarding the DCSA HIV/AIDS Workplace Project. 
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SIGNIFICANT RESULTS TO BE ANALYSED 
 
The response to the following questions in Section B Part 2, “Your 
Opinion”, was identified as significant.  All these questions had 20 per cent 
or more respondents who were either uncertain, disagreed or strongly 
disagreed with the statement.  The following questions will be statistically 
analysed 
in terms of employment level, gender and age. 
 
Question 2.1   I am confident that staff at OHS maintain confidentiality       
                         regarding employees’ HIV status.  
 
Question 3.1   I understand what ART entails. 
 
Question 3.2   I am aware of the benefits of ART and of joining AfA. 
 
Question 4.1   I am aware of the HIV/AIDS support and treatment offered  
                         to HIV/AIDS employees and their families.   
 
Question 5.1   I am confident that peer educators are well trained and  
                         equipped to deal with HIV/AIDS issues. 
 
Question 6.1   I am concerned that HIV/AIDS employees face  
                         discrimination in the workplace. 
 
Question 6.3   I believe DCSA HIV/AIDS Workplace Project has reduced  
                         the stigma attached to HIV/AIDS. 
 
Question 7     I am aware of the following impacts of HIV/AIDS in my  
                        department:  Loss of productivity; Rise in cost;                    
                        Absenteeism. 
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EMPLOYMENT LEVEL 
 
The total sample was represented as follows:   
Hourly paid employees 60 per cent, Management 20 per cent and 
Administrative 20 per cent. 
 
In this section significant response to questions in Section B Part 2 will be 
analysed in terms of Employment Level. 
 
Question 1.1 below will serve as an example of how the rest of the tables 
should be interpreted. 
  
Question 1.1 
2-Way Tables of Descriptive Statistics
N=50 (No missing data in dep. var. list)
Group
P2_Q1_1
Means
P2_Q1_1
N
P2_Q1_1
Std.Dev.
Admin
Management
Hourly
All Grps
1.600000 10 0.516398
1.500000 10 0.527046
1.466667 30 0.681445
1.500000 50 0.614452  
Analysis of Variance
Marked effects are significant at p < .05000
Variable
SS
Effect
df
Effect
MS
Effect
SS
Error
df
Error
MS
Error
F p
P2_Q1_1 0.133333 2 0.066667 18.36667 47 0.390780 0.170599 0.843679  
 
The above two tables give the results when comparing the three 
employment levels on question P2_Q1_1.  The first table gives the 
average response for each of the three groups, as well as the overall 
average.  One can see how the three groups differ with respect to their 
average response on this question, as well as how they compare to the 
overall average.  It can be seen that there is not much difference between 
the three groups since the averages are close to each other. 
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The second table gives the results of an Analysis of Variance that was 
performed in order to test whether the means of the three groups differ 
significantly, i.e. whether there is a statistically significant difference 
among the three group means.  The only figure of interest is the last one, 
under “p”.  This value is called the p-value for the test and if it is smaller 
than 0,05 we conclude that there is a statistically significant (on the 5% 
level of significance) difference among the three averages.  In this case 
the p-value is greater than 0,05 and therefore the conclusion is that the 
three groups do not differ significantly in terms of their average response 
on this question.  
 
The rest of the tables are interpreted similarly. 
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Question 2.1   
2-Way Tables of Descriptive Statistics
N=50 (No missing data in dep. var. list)
Group
P2_Q2_1
Means
P2_Q2_1
N
P2_Q2_1
Std.Dev.
Admin
Management
Hourly
All Grps
2.300000 10 1.337494
1.800000 10 0.788811
2.066667 30 1.080655
2.060000 50 1.076843  
Analysis of Variance
Marked effects are significant at p < .05000
Variable
SS
Effect
df
Effect
MS
Effect
SS
Error
df
Error
MS
Error
F p
P2_Q2_1 1.253333 2 0.626667 55.56667 47 1.182270 0.530054 0.592050  
 
 
Question 3.1 
2-Way Tables of Descriptive Statistics
N=50 (No missing data in dep. var. list)
Group
P2_Q3_1
Means
P2_Q3_1
N
P2_Q3_1
Std.Dev.
Admin
Management
Hourly
All Grps
2.400000 10 0.966092
2.300000 10 0.823273
1.733333 30 0.691492
1.980000 50 0.820403
Analysis of Variance
Marked effects are significant at p < .05000
Variable
SS
Effect
df
Effect
MS
Effect
SS
Error
df
Error
MS
Error
F p
P2_Q3_1 4.613333 2 2.306667 28.36667 47 0.603546 3.821857 0.028980  
Duncan test; Variable: P2_Q3_1
Marked differences are significant at p < .05000
Group
{1}
M=2.4000
{2}
M=2.3000
{3}
M=1.7333
Admin    {1}
Management {2}
Hourly   {3}
0.745726 0.043979
0.745726 0.070805
0.043979 0.070805  
 
In the above analysis there is now an extra table.  This is because the 
Anova indicates that the group means differ significantly, but it does not 
distinguish between which groups the significant differences are.  The third 
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table gives that information, and in this case the only significant difference 
is between Admin (mean=2.4) and Hourly (mean=1.73). 
 
Question 3.2 
2-Way Tables of Descriptive Statistics
N=50 (No missing data in dep. var. list)
Group
P2_Q3_2
Means
P2_Q3_2
N
P2_Q3_2
Std.Dev.
Admin
Management
Hourly
All Grps
2.400000 10 0.843274
2.200000 10 0.788811
1.766667 30 0.897634
1.980000 50 0.891914
 
Analysis of Variance
Marked effects are significant at p < .05000
Variable
SS
Effect
df
Effect
MS
Effect
SS
Error
df
Error
MS
Error
F p
P2_Q3_2 3.613333 2 1.806667 35.36667 47 0.752482 2.400943 0.101667  
 
 
Question 4.1 
2-Way Tables of Descriptive Statistics
N=50 (No missing data in dep. var. list)
Group
P2_Q4_1
Means
P2_Q4_1
N
P2_Q4_1
Std.Dev.
Admin
Management
Hourly
All Grps
2.600000 10 0.516398
1.800000 10 0.918937
1.866667 30 1.074255
2.000000 50 0.989743  
Analysis of Variance
Marked effects are significant at p < .05000
Variable
SS
Effect
df
Effect
MS
Effect
SS
Error
df
Error
MS
Error
F p
P2_Q4_1 4.533333 2 2.266667 43.46667 47 0.924823 2.450920 0.097164  
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Question 5.1 
2-Way Tables of Descriptive Statistics
N=50 (No missing data in dep. var. list)
Group
P2_Q5_1
Means
P2_Q5_1
N
P2_Q5_1
Std.Dev.
Admin
Management
Hourly
All Grps
2.300000 10 0.823273
2.200000 10 0.632456
2.133333 30 1.074255
2.180000 50 0.940907  
Analysis of Variance
Marked effects are significant at p < .05000
Variable
SS
Effect
df
Effect
MS
Effect
SS
Error
df
Error
MS
Error
F p
P2_Q5_1 0.213333 2 0.106667 43.16667 47 0.918440 0.116139 0.890606  
 
 
Question 6.1 
2-Way Tables of Descriptive Statistics
N=50 (No missing data in dep. var. list)
Group
P2_Q6_1
Means
P2_Q6_1
N
P2_Q6_1
Std.Dev.
Admin
Management
Hourly
All Grps
2.800000 10 0.788811
3.000000 10 1.054093
2.900000 30 1.446756
2.900000 50 1.249490  
Analysis of Variance
Marked effects are significant at p < .05000
Variable
SS
Effect
df
Effect
MS
Effect
SS
Error
df
Error
MS
Error
F p
P2_Q6_1 0.200000 2 0.100000 76.30000 47 1.623404 0.061599 0.940336  
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Question 6.3 
2-Way Tables of Descriptive Statistics
N=50 (No missing data in dep. var. list)
Group
P2_Q6_3
Means
P2_Q6_3
N
P2_Q6_3
Std.Dev.
Admin
Management
Hourly
All Grps
2.200000 10 0.788811
2.000000 10 0.666667
2.100000 30 1.155198
2.100000 50 0.994885
 
Analysis of Variance
Marked effects are significant at p < .05000
Variable
SS
Effect
df
Effect
MS
Effect
SS
Error
df
Error
MS
Error
F p
P2_Q6_3 0.200000 2 0.100000 48.30000 47 1.027660 0.097308 0.907458  
 
 
Question 7 
2-Way Tables of Descriptive Statistics
N=50 (No missing data in dep. var. list)
Group
P2_Q7_ave
Means
P2_Q7_ave
N
P2_Q7_ave
Std.Dev.
Admin
Management
Hourly
All Grps
1.966667 10 0.674949
1.700000 10 0.823273
2.077778 30 1.099228
1.980000 50 0.972199  
Analysis of Variance
Marked effects are significant at p < .05000
Variable
SS
Effect
df
Effect
MS
Effect
SS
Error
df
Error
MS
Error
F p
P2_Q7_ave 1.072593 2 0.536296 45.24074 47 0.962569 0.557151 0.576575
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GENDER 
 
A sample of 37 (74 per cent) males and 13 (26 per cent) females from the 
workforce completed the questionnaire. 
 
In this section significant response to questions in Section B Part 2 will be 
analysed in terms of Gender. 
 
Question 2.1 
2-Way Tables of Descriptive Statistics
N=50 (No missing data in dep. var. list)
Gender
P2_Q2_1
Means
P2_Q2_1
N
P2_Q2_1
Std.Dev.
Male
Female
All Grps
1.837838 37 0.833784
2.692308 13 1.436698
2.060000 50 1.076843  
Analysis of Variance
Marked effects are significant at p < .05000
Variable
SS
Effect
df
Effect
MS
Effect
SS
Error
df
Error
MS
Error
F p
P2_Q2_1 7.023742 1 7.023742 49.79626 48 1.037422 6.770381 0.012289  
 
In the above analysis there is not a third table with the post-hoc test.  It is 
because there are only two categories and if the Anova shows a 
significant difference, it can only be between the two categories. 
 
 
Question 3.1 
2-Way Tables of Descriptive Statistics
N=50 (No missing data in dep. var. list)
Gender
P2_Q3_1
Means
P2_Q3_1
N
P2_Q3_1
Std.Dev.
Male
Female
All Grps
1.864865 37 0.751375
2.307692 13 0.947331
1.980000 50 0.820403  
Analysis of Variance
Marked effects are significant at p < .05000
Variable
SS
Effect
df
Effect
MS
Effect
SS
Error
df
Error
MS
Error
F p
P2_Q3_1 1.886445 1 1.886445 31.09356 48 0.647782 2.912158 0.094377  
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Question 3.2 
2-Way Tables of Descriptive Statistics
N=50 (No missing data in dep. var. list)
Gender
P2_Q3_2
Means
P2_Q3_2
N
P2_Q3_2
Std.Dev.
Male
Female
All Grps
1.891892 37 0.875080
2.230769 13 0.926809
1.980000 50 0.891914  
Analysis of Variance
Marked effects are significant at p < .05000
Variable
SS
Effect
df
Effect
MS
Effect
SS
Error
df
Error
MS
Error
F p
P2_Q3_2 1.104740 1 1.104740 37.87526 48 0.789068 1.400057 0.242541  
 
 
Question 4.1 
2-Way Tables of Descriptive Statistics
N=50 (No missing data in dep. var. list)
Gender
P2_Q4_1
Means
P2_Q4_1
N
P2_Q4_1
Std.Dev.
Male
Female
All Grps
1.810811 37 0.967179
2.538462 13 0.877058
2.000000 50 0.989743  
Analysis of Variance
Marked effects are significant at p < .05000
Variable
SS
Effect
df
Effect
MS
Effect
SS
Error
df
Error
MS
Error
F p
P2_Q4_1 5.093555 1 5.093555 42.90644 48 0.893884 5.698227 0.020970  
 
In the above analysis the p-value is smaller than 0,05.  Thus the Anova 
indicates that the group means differ significantly.  The conclusion is that 
the two groups (male and female) differ significantly in terms of their 
average response on this question. 
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Question 5.1 
2-Way Tables of Descriptive Statistics
N=50 (No missing data in dep. var. list)
Gender
P2_Q5_1
Means
P2_Q5_1
N
P2_Q5_1
Std.Dev.
Male
Female
All Grps
2.054054 37 0.911225
2.538462 13 0.967418
2.180000 50 0.940907  
Analysis of Variance
Marked effects are significant at p < .05000
Variable
SS
Effect
df
Effect
MS
Effect
SS
Error
df
Error
MS
Error
F p
P2_Q5_1 2.257339 1 2.257339 41.12266 48 0.856722 2.634855 0.111092  
 
 
Question 6.1 
2-Way Tables of Descriptive Statistics
N=50 (No missing data in dep. var. list)
Gender
P2_Q6_1
Means
P2_Q6_1
N
P2_Q6_1
Std.Dev.
Male
Female
All Grps
2.945946 37 1.332207
2.769231 13 1.012739
2.900000 50 1.249490  
Analysis of Variance
Marked effects are significant at p < .05000
Variable
SS
Effect
df
Effect
MS
Effect
SS
Error
df
Error
MS
Error
F p
P2_Q6_1 0.300416 1 0.300416 76.19958 48 1.587491 0.189239 0.665500  
 
 
Question 6.3 
2-Way Tables of Descriptive Statistics
N=50 (No missing data in dep. var. list)
Gender
P2_Q6_3
Means
P2_Q6_3
N
P2_Q6_3
Std.Dev.
Male
Female
All Grps
1.972973 37 0.957035
2.461538 13 1.050031
2.100000 50 0.994885  
Analysis of Variance
Marked effects are significant at p < .05000
Variable
SS
Effect
df
Effect
MS
Effect
SS
Error
df
Error
MS
Error
F p
P2_Q6_3 2.296258 1 2.296258 46.20374 48 0.962578 2.385529 0.129031  
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Question 7 
2-Way Tables of Descriptive Statistics
N=50 (No missing data in dep. var. list)
Gender
P2_Q7_ave
Means
P2_Q7_ave
N
P2_Q7_ave
Std.Dev.
Male
Female
All Grps
1.954955 37 1.015808
2.051282 13 0.869718
1.980000 50 0.972199  
Analysis of Variance
Marked effects are significant at p < .05000
Variable
SS
Effect
df
Effect
MS
Effect
SS
Error
df
Error
MS
Error
F p
P2_Q7_ave 0.089263 1 0.089263 46.22407 48 0.963001 0.092693 0.762098
 
 
AGE 
 
The age of respondents varied from 21 – 60 years.  The highest frequency 
was found in the 31 – 40 year age group and this corresponds with the 
actual age breakdown of employees at DCSA, hence comparability is 
possible. 
 
In this section significant response to questions in Section B Part 2 will be 
analysed in terms of Age. 
 
Question 2.1 
2-Way Tables of Descriptive Statistics
N=50 (No missing data in dep. var. list)
Age
P2_Q2_1
Means
P2_Q2_1
N
P2_Q2_1
Std.Dev.
21 - 30 yrs
31 - 40 yrs
41 - 50 yrs
51 - 60 yrs
All Grps
2.214286 14 0.892582
2.105263 19 1.242521
2.000000 12 1.128152
1.600000 5 0.894427
2.060000 50 1.076843  
Analysis of Variance
Marked effects are significant at p < .05000
Variable
SS
Effect
df
Effect
MS
Effect
SS
Error
df
Error
MS
Error
F p
P2_Q2_1 1.473383 3 0.491128 55.34662 46 1.203187 0.408189 0.747843  
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Question 3.1 
2-Way Tables of Descriptive Statistics
N=50 (No missing data in dep. var. list)
Age
P2_Q3_1
Means
P2_Q3_1
N
P2_Q3_1
Std.Dev.
21 - 30 yrs
31 - 40 yrs
41 - 50 yrs
51 - 60 yrs
All Grps
2.142857 14 0.949262
1.736842 19 0.733493
2.333333 12 0.778499
1.600000 5 0.547723
1.980000 50 0.820403  
Analysis of Variance
Marked effects are significant at p < .05000
Variable
SS
Effect
df
Effect
MS
Effect
SS
Error
df
Error
MS
Error
F p
P2_Q3_1 3.714837 3 1.238279 29.26516 46 0.636199 1.946370 0.135340  
 
 
Question 3.2 
2-Way Tables of Descriptive Statistics
N=50 (No missing data in dep. var. list)
Age
P2_Q3_2
Means
P2_Q3_2
N
P2_Q3_2
Std.Dev.
21 - 30 yrs
31 - 40 yrs
41 - 50 yrs
51 - 60 yrs
All Grps
2.142857 14 1.099450
1.736842 19 0.871914
2.250000 12 0.621582
1.800000 5 0.836660
1.980000 50 0.891914  
Analysis of Variance
Marked effects are significant at p < .05000
Variable
SS
Effect
df
Effect
MS
Effect
SS
Error
df
Error
MS
Error
F p
P2_Q3_2 2.531504 3 0.843835 36.44850 46 0.792359 1.064965 0.373207  
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Question 4.1 
2-Way Tables of Descriptive Statistics
N=50 (No missing data in dep. var. list)
Age
P2_Q4_1
Means
P2_Q4_1
N
P2_Q4_1
Std.Dev.
21 - 30 yrs
31 - 40 yrs
41 - 50 yrs
51 - 60 yrs
All Grps
2.071429 14 1.071612
2.157895 19 1.067872
1.833333 12 0.937437
1.600000 5 0.547723
2.000000 50 0.989743  
Analysis of Variance
Marked effects are significant at p < .05000
Variable
SS
Effect
df
Effect
MS
Effect
SS
Error
df
Error
MS
Error
F p
P2_Q4_1 1.678446 3 0.559482 46.32155 46 1.006990 0.555598 0.647009  
 
 
Question 5.1 
2-Way Tables of Descriptive Statistics
N=50 (No missing data in dep. var. list)
Age
P2_Q5_1
Means
P2_Q5_1
N
P2_Q5_1
Std.Dev.
21 - 30 yrs
31 - 40 yrs
41 - 50 yrs
51 - 60 yrs
All Grps
2.428571 14 1.222500
2.210526 19 0.976328
2.000000 12 0.603023
1.800000 5 0.447214
2.180000 50 0.940907  
Analysis of Variance
Marked effects are significant at p < .05000
Variable
SS
Effect
df
Effect
MS
Effect
SS
Error
df
Error
MS
Error
F p
P2_Q5_1 1.993534 3 0.664511 41.38647 46 0.899706 0.738587 0.534460  
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Question 6.1 
2-Way Tables of Descriptive Statistics
N=50 (No missing data in dep. var. list)
Age
P2_Q6_1
Means
P2_Q6_1
N
P2_Q6_1
Std.Dev.
21 - 30 yrs
31 - 40 yrs
41 - 50 yrs
51 - 60 yrs
All Grps
2.857143 14 1.292412
3.000000 19 1.290994
2.916667 12 1.164500
2.600000 5 1.516575
2.900000 50 1.249490  
Analysis of Variance
Marked effects are significant at p < .05000
Variable
SS
Effect
df
Effect
MS
Effect
SS
Error
df
Error
MS
Error
F p
P2_Q6_1 0.669048 3 0.223016 75.83095 46 1.648499 0.135284 0.938497  
 
 
Question 6.3 
2-Way Tables of Descriptive Statistics
N=50 (No missing data in dep. var. list)
Age
P2_Q6_3
Means
P2_Q6_3
N
P2_Q6_3
Std.Dev.
21 - 30 yrs
31 - 40 yrs
41 - 50 yrs
51 - 60 yrs
All Grps
2.428571 14 1.089410
1.947368 19 1.129094
1.916667 12 0.668558
2.200000 5 0.836660
2.100000 50 0.994885  
Analysis of Variance
Marked effects are significant at p < .05000
Variable
SS
Effect
df
Effect
MS
Effect
SS
Error
df
Error
MS
Error
F p
P2_Q6_3 2.407393 3 0.802464 46.09261 46 1.002013 0.800852 0.499800  
 
 
 
 
 
ANNEXURE 4 
  - 18 -  
 
Question 7 
2-Way Tables of Descriptive Statistics
N=50 (No missing data in dep. var. list)
Age
P2_Q7_ave
Means
P2_Q7_ave
N
P2_Q7_ave
Std.Dev.
21 - 30 yrs
31 - 40 yrs
41 - 50 yrs
51 - 60 yrs
All Grps
2.380952 14 1.338817
1.684211 19 0.827563
2.222222 12 0.538110
1.400000 5 0.547723
1.980000 50 0.972199  
Analysis of Variance
Marked effects are significant at p < .05000
Variable
SS
Effect
df
Effect
MS
Effect
SS
Error
df
Error
MS
Error
F p
P2_Q7_ave 6.299075 3 2.099692 40.01426 46 0.869875 2.413785 0.078675
 
 
 
RESPONDENTS’ UNDERSTANDING OF HIV/AIDS ANALYSED 
 
 
In this section, the relationship between Section B Part 1 and Part 2, will 
be analysed using only the selected questions. 
 
Section B  Part 1 
Question 4 Can  HIV be cured if diagnosed early and treated? 
Question 6 Is HIV spread only through sexual intercourse with an     
                      infected person? 
 
Section B  Part 2 
Questions   2.1;  3.1;  3.2;  4.1;  5.1;  6.1;  6.3;  7 (as described in 
introduction). 
 
One way of looking at the relationship is to see whether the ‘Wrong’ and 
‘Right’ groups on Questions 4 and 6 of Part 1 have the same averages on 
the Questions in Part 2.  Question 4 and 6 had been recoded to Right or 
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Wrong, where Not sure was taken as the wrong answer.  If there is no big 
difference between these averages, one can say that there is no 
relationship, otherwise there is some relationship.  The Anova test is used 
for this.   
 
For example, the first two tables can be used to explore the relationship 
between Q 4 and P2_Q2_1.  It seems that the ‘Wrong’ group on average 
did not agree to the statement as strongly as the ‘Right’ group, since the 
higher average means they tend to be more to the right hand side of the 
scale, the Disagree side.  The second table, however, shows that this 
difference is not statistically significant (it is greater than 0.05).  
 
The relationship between Part 1 Question 4 and Part 2 Question 2.1 
2-Way Tables of Descriptive Statistics
N=50 (No missing data in dep. var. list)
B_4_recode
P2_Q2_1
Means
P2_Q2_1
N
P2_Q2_1
Std.Dev.
Wrong
Right
All Grps
2.333333 18 1.283378
1.906250 32 0.928383
2.060000 50 1.076843  
Analysis of Variance
Marked effects are significant at p < .05000
Variable
SS
Effect
df
Effect
MS
Effect
SS
Error
df
Error
MS
Error
F p
P2_Q2_1 2.101250 1 2.101250 54.71875 48 1.139974 1.843244 0.180920  
 
 
The relationship between Part 1 Question 4 and Part 2 Question 3.1 
2-Way Tables of Descriptive Statistics
N=50 (No missing data in dep. var. list
B_4_recode
P2_Q3_1
Means
P2_Q3_1
N
P2_Q3_1
Std.Dev.
Wrong
Right
All Grps
2.055556 18 0.872604
1.937500 32 0.800705
1.980000 50 0.820403  
Analysis of Variance
Marked effects are significant at p < .05000
Variable
SS
Effect
df
Effect
MS
Effect
SS
Error
df
Error
MS
Error
F p
P2_Q3_1 0.160556 1 0.160556 32.81944 48 0.683738 0.234820 0.630177  
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The relationship between Part 1 Question 4 and Part 2 Question 3.2 
2-Way Tables of Descriptive Statistics
N=50 (No missing data in dep. var. list)
B_4_recode
P2_Q3_2
Means
P2_Q3_2
N
P2_Q3_2
Std.Dev.
Wrong
Right
All Grps
2.055556 18 0.872604
1.937500 32 0.913607
1.980000 50 0.891914  
Analysis of Variance
Marked effects are significant at p < .05000
Variable
SS
Effect
df
Effect
MS
Effect
SS
Error
df
Error
MS
Error
F p
P2_Q3_2 0.160556 1 0.160556 38.81944 48 0.808738 0.198526 0.657917  
 
 
The relationship between Part 1 Question 4 and Part 2 Question 4.1 
2-Way Tables of Descriptive Statistics
N=50 (No missing data in dep. var. list
B_4_recode
P2_Q4_1
Means
P2_Q4_1
N
P2_Q4_1
Std.Dev.
Wrong
Right
All Grps
1.888889 18 0.963382
2.062500 32 1.014015
2.000000 50 0.989743  
Analysis of Variance
Marked effects are significant at p < .05000
Variable
SS
Effect
df
Effect
MS
Effect
SS
Error
df
Error
MS
Error
F p
P2_Q4_1 0.347222 1 0.347222 47.65278 48 0.992766 0.349752 0.557028  
 
 
The relationship between Part 1 Question 4 and Part 2 Question 5.1   
2-Way Tables of Descriptive Statistics
N=50 (No missing data in dep. var. list)
B_4_recode
P2_Q5_1
Means
P2_Q5_1
N
P2_Q5_1
Std.Dev.
Wrong
Right
All Grps
2.277778 18 1.017815
2.125000 32 0.906962
2.180000 50 0.940907  
Analysis of Variance
Marked effects are significant at p < .05000
Variable
SS
Effect
df
Effect
MS
Effect
SS
Error
df
Error
MS
Error
F p
P2_Q5_1 0.268889 1 0.268889 43.11111 48 0.898148 0.299381 0.586806  
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The relationship between Part 1 Question 4 and Part 2 Question 6.1 
2-Way Tables of Descriptive Statistics
N=50 (No missing data in dep. var. list)
B_4_recode
P2_Q6_1
Means
P2_Q6_1
N
P2_Q6_1
Std.Dev.
Wrong
Right
All Grps
2.833333 18 1.339447
2.937500 32 1.216486
2.900000 50 1.249490  
Analysis of Variance
Marked effects are significant at p < .05000
Variable
SS
Effect
df
Effect
MS
Effect
SS
Error
df
Error
MS
Error
F p
P2_Q6_1 0.125000 1 0.125000 76.37500 48 1.591146 0.078560 0.780463  
 
 
The relationship between Part 1 Question 4 and Part 2 Question 6.3  
2-Way Tables of Descriptive Statistics
N=50 (No missing data in dep. var. list
B_4_recode
P2_Q6_3
Means
P2_Q6_3
N
P2_Q6_3
Std.Dev.
Wrong
Right
All Grps
2.111111 18 1.078610
2.093750 32 0.962503
2.100000 50 0.994885  
Analysis of Variance
Marked effects are significant at p < .05000
Variable
SS
Effect
df
Effect
MS
Effect
SS
Error
df
Error
MS
Error
F p
P2_Q6_3 0.003472 1 0.003472 48.49653 48 1.010344 0.003437 0.953496  
 
 
The relationship between Part 1 Question 4 and Part 2 Question 7  
2-Way Tables of Descriptive Statistics
N=50 (No missing data in dep. var. list)
B_4_recode
P2_Q7_ave
Means
P2_Q7_ave
N
P2_Q7_ave
Std.Dev.
Wrong
Right
All Grps
2.037037 18 0.854736
1.947917 32 1.044217
1.980000 50 0.972199  
Analysis of Variance
Marked effects are significant at p < .05000
Variable
SS
Effect
df
Effect
MS
Effect
SS
Error
df
Error
MS
Error
F p
P2_Q7_ave 0.091497 1 0.091497 46.22184 48 0.962955 0.095017 0.759227
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The relationship between Part 1 Question 6 and Part 2 Question 2.1 
2-Way Tables of Descriptive Statistics
N=50 (No missing data in dep. var. list)
B_6_recode
P2_Q2_1
Means
P2_Q2_1
N
P2_Q2_1
Std.Dev.
Wrong
Right
All Grps
1.846154 13 0.987096
2.135135 37 1.109609
2.060000 50 1.076843  
Analysis of Variance
Marked effects are significant at p < .05000
Variable
SS
Effect
df
Effect
MS
Effect
SS
Error
df
Error
MS
Error
F p
P2_Q2_1 0.803368 1 0.803368 56.01663 48 1.167013 0.688397 0.410818  
 
 
The relationship between Part 1 Question 6 and Part 2 Question 3.1 
2-Way Tables of Descriptive Statistics
N=50 (No missing data in dep. var. list)
B_6_recode
P2_Q3_1
Means
P2_Q3_1
N
P2_Q3_1
Std.Dev.
Wrong
Right
All Grps
1.692308 13 0.751068
2.081081 37 0.829269
1.980000 50 0.820403  
Analysis of Variance
Marked effects are significant at p < .05000
Variable
SS
Effect
df
Effect
MS
Effect
SS
Error
df
Error
MS
Error
F p
P2_Q3_1 1.454012 1 1.454012 31.52599 48 0.656791 2.213812 0.143321  
 
 
The relationship between Part 1 Question 6 and Part 2 Question 3.2 
2-Way Tables of Descriptive Statistics
N=50 (No missing data in dep. var. list)
B_6_recode
P2_Q3_2
Means
P2_Q3_2
N
P2_Q3_2
Std.Dev.
Wrong
Right
All Grps
1.769231 13 0.832050
2.054054 37 0.911225
1.980000 50 0.891914  
Analysis of Variance
Marked effects are significant at p < .05000
Variable
SS
Effect
df
Effect
MS
Effect
SS
Error
df
Error
MS
Error
F p
P2_Q3_2 0.780416 1 0.780416 38.19958 48 0.795825 0.980638 0.327007  
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The relationship between Part 1 Question 6 and Part 2 Question 4.1 
2-Way Tables of Descriptive Statistics
N=50 (No missing data in dep. var. list
B_6_recode
P2_Q4_1
Means
P2_Q4_1
N
P2_Q4_1
Std.Dev.
Wrong
Right
All Grps
1.769231 13 1.012739
2.081081 37 0.982581
2.000000 50 0.989743  
Analysis of Variance
Marked effects are significant at p < .05000
Variable
SS
Effect
df
Effect
MS
Effect
SS
Error
df
Error
MS
Error
F p
P2_Q4_1 0.935551 1 0.935551 47.06445 48 0.980509 0.954148 0.333563  
 
 
The relationship between Part 1 Question 6 and Part 2 Question 5.1 
2-Way Tables of Descriptive Statistics
N=50 (No missing data in dep. var. list
B_6_recode
P2_Q5_1
Means
P2_Q5_1
N
P2_Q5_1
Std.Dev.
Wrong
Right
All Grps
2.000000 13 0.912871
2.243243 37 0.954679
2.180000 50 0.940907  
Analysis of Variance
Marked effects are significant at p < .05000
Variable
SS
Effect
df
Effect
MS
Effect
SS
Error
df
Error
MS
Error
F p
P2_Q5_1 0.569189 1 0.569189 42.81081 48 0.891892 0.638182 0.428305  
 
 
The relationship between Part 1 Question 6 and Part 2 Question 6.1 
2-Way Tables of Descriptive Statistics
N=50 (No missing data in dep. var. list
B_6_recode
P2_Q6_1
Means
P2_Q6_1
N
P2_Q6_1
Std.Dev.
Wrong
Right
All Grps
3.230769 13 1.165751
2.783784 37 1.272249
2.900000 50 1.249490  
Analysis of Variance
Marked effects are significant at p < .05000
Variable
SS
Effect
df
Effect
MS
Effect
SS
Error
df
Error
MS
Error
F p
P2_Q6_1 1.922037 1 1.922037 74.57796 48 1.553708 1.237065 0.271577  
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The relationship between Part 1 Question 6 and Part 2 Question 6.3 
2-Way Tables of Descriptive Statistics
N=50 (No missing data in dep. var. list)
B_6_recode
P2_Q6_3
Means
P2_Q6_3
N
P2_Q6_3
Std.Dev.
Wrong
Right
All Grps
2.153846 13 1.214232
2.081081 37 0.924313
2.100000 50 0.994885  
Analysis of Variance
Marked effects are significant at p < .05000
Variable
SS
Effect
df
Effect
MS
Effect
SS
Error
df
Error
MS
Error
F p
P2_Q6_3 0.050936 1 0.050936 48.44906 48 1.009356 0.050463 0.823212  
 
 
The relationship between Part 1 Question 6 and Part 2 Question 7 
2-Way Tables of Descriptive Statistics
N=50 (No missing data in dep. var. list)
B_6_recode
P2_Q7_ave
Means
P2_Q7_ave
N
P2_Q7_ave
Std.Dev.
Wrong
Right
All Grps
1.769231 13 0.671987
2.054054 37 1.055595
1.980000 50 0.972199  
Analysis of Variance
Marked effects are significant at p < .05000
Variable
SS
Effect
df
Effect
MS
Effect
SS
Error
df
Error
MS
Error
F p
P2_Q7_ave 0.780416 1 0.780416 45.53292 48 0.948602 0.822701 0.368923
 
 
 
FREQUENCY TABLES 
 
 
The following analyses are two-way frequency tables showing how groups 
differed in terms of their response to a specific question.  For example, the 
first table shows how the employment levels differed in terms of their 
response to Question 4 in Section B  Part 1 (recoded to Right or Wrong, 
where the Not sure was taken as a wrong answer).  The differences 
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between the three groups can now clearly be seen if one looks at the row 
percentages.  In the Admin group, 2 out of the 10 (i.e. 20 per cent) gave 
the wrong answer to Q4, while 3 (30 per cent) in the Management group 
and 13 (43,33 per cent) in the Hourly group gave the wrong answer. 
 
 
The relationship between Part 1 Question 4 and Employment level 
Summary Frequency Table
Table: Group(3) x B_4_recode(2)
Group B_4_recode
Wrong
B_4_recode
Right
Row
Totals
Count
Row Percent
Count
Row Percent
Count
Row Percent
Count
Admin 2 8 10
20.00% 80.00%
Management 3 7 10
30.00% 70.00%
Hourly 13 17 30
43.33% 56.67%
All Grps 18 32 50  
 
 
The relationship between Part 1 Question 6 and employment level 
Summary Frequency Table
Table: Group(3) x B_6_recode(2)
Group B_6_recode
Wrong
B_6_recode
Right
Row
Totals
Count
Row Percent
Count
Row Percent
Count
Row Percent
Count
Admin 2 8 10
20.00% 80.00%
Management 2 8 10
20.00% 80.00%
Hourly 9 21 30
30.00% 70.00%
All Grps 13 37 50  
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The relationship between Part 1 Question 4 and Age 
Summary Frequency Table
Table: Age(4) x B_4_recode(2)
Age B_4_recode
Wrong
B_4_recode
Right
Row
Totals
Count
Row Percent
Count
Row Percent
Count
Row Percent
Count
Row Percent
Count
21 - 30 yrs 2 12 14
14.29% 85.71%
31 - 40 yrs 9 10 19
47.37% 52.63%
41 - 50 yrs 6 6 12
50.00% 50.00%
51 - 60 yrs 1 4 5
20.00% 80.00%
All Grps 18 32 50
 
 
 
The relationship between Part 1 Question 6 and Age 
Summary Frequency Table
Table: Age(4) x B_6_recode(2)
Age B_6_recode
Wrong
B_6_recode
Right
Row
Totals
Count
Row Percent
Count
Row Percent
Count
Row Percent
Count
Row Percent
Count
21 - 30 yrs 2 12 14
14.29% 85.71%
31 - 40 yrs 4 15 19
21.05% 78.95%
41 - 50 yrs 6 6 12
50.00% 50.00%
51 - 60 yrs 1 4 5
20.00% 80.00%
All Grps 13 37 50
 
 
 
The relationship between Part 1 Question 4 and Gender 
Summary Frequency Table
Table: Gender(2) x B_4_recode(2)
Gender B_4_recode
Wrong
B_4_recode
Right
Row
Totals
Count
Row Percent
Count
Row Percent
Count
Male 14 23 37
37.84% 62.16%
Female 4 9 13
30.77% 69.23%
All Grps 18 32 50  
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The relationship between Part 1 Question 6 and Gender 
Summary Frequency Table
Table: Gender(2) x B_6_recode(2)
Gender B_6_recode
Wrong
B_6_recode
Right
Row
Totals
Count
Row Percent
Count
Row Percent
Count
Male 10 27 37
27.03% 72.97%
Female 3 10 13
23.08% 76.92%
All Grps 13 37 50  
 
 
 
 
CONCLUSION 
 
From the above statistical analyses the following can be noted: 
 
• Part 2  Q 2.1 -  I am confident that staff at OHS maintain 
confidentiality regarding employees’ HIV status.   
The Anova shows a significant difference of group means between 
male (mean = 1.83) and female (mean = 2.69) respondents.  
• Part 2  Q 3.1 -  I understand what ART entails. 
The Anova shows a significant difference of group means between 
Hourly paid (mean = 1.73) and Administrative employees (mean = 
2.4). 
• Part 2  Q 4.1 -  I am aware of the HIV/AIDS support and treatment 
offered to HIV/AIDS workers and their families.    
The Anova shows a significant difference of group means between 
male (mean = 1.81) and female (2.53) respondents. 
• The two-way frequency tables showed that in the Age group 41 – 
50 years, 50 per cent of the respondents gave the wrong answer to 
Part 1 Question 4 and 6. 
